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Abstract 
The m-AAA protease, an ATP-dependent proteolytic complex in the inner mitochondrial 
membrane, controls mitochondrial protein quality and, acting as a processing enzyme, 
regulates mitochondrial protein synthesis in yeast. Mammalian m-AAA proteases assemble 
into several isoenzymes with variable subunit composition. In mice, the three different 
subunits paraplegin, Afg3l1 and Afg3l2, are expressed in a tissue-specific manner. Loss-of-
function mutations in the m-AAA protease subunit paraplegin cause the neurodegenerative 
disease hereditary spastic paraplegia (HSP) which is mainly characterized by a cell-specific 
axonal degeneration. Similarly, Afg3l2 mutant mice exhibit neuropathological features with a 
severe defect in axonal development. The molecular basis of these neuron-specific 
phenotypes as well as cellular functions of mammalian m-AAA proteases in general remain 
unclear and are studied within this thesis.  
Using an HSP mouse model lacking paraplegin, a liver-specific mitochondrial translation 
defect was observed which is consistent with a functional conservation of the m-AAA 
protease-dependent control of mitochondrial protein synthesis in mammals. However, a 
significant impairment of mitochondrial protein synthesis and mitochondrial respiration in 
brain and spinal cord was not observed suggesting that axonal degeneration in HSP due to a 
loss of paraplegin occurs in the absence of a general respiratory dysfunction.  
The analysis of m-AAA isoenzymes on a cellular level using RNA interference revealed 
redundant functions of the subunits Afg3l1 and Afg3l2 and identified paraplegin as a new 
substrate which is processed by Afg3l1 and Afg3l2. Depletion of the m-AAA protease in 
MEFs resulted in mitochondrial fragmentation accompanied by an impaired biogenesis of 
OPA1, an essential component of the mitochondrial fusion machinery. Long OPA1 isoforms 
were destabilized and cleaved in an accelerated manner. The overexpression of a non-
cleavable long OPA1 isoform in m-AAA protease-depleted cells restored the tubular 
mitochondrial network identifying impaired OPA1 processing as the primary cause for the 
mitochondrial morphology defect. Furthermore, the m-AAA protease was found to be 
essential for inducing mitochondrial hyperfusion, a cellular stress response which results in a 
highly interconnected mitochondrial network.  
The findings of this study indicate that the m-AAA protease has crucial functions in the 
regulation of mitochondrial morphology by controlling the biogenesis of OPA1 isoforms 
which may provide new insights into the molecular mechanisms of axonopathies caused by 
the loss of m-AAA protease subunits in mammals. 
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Introduction 7
1 Introduction 
 
1.1 The proteolytic system of mitochondria 
Mitochondria are essential organelles in eukaryotic cells which house biosynthetic 
pathways and generate ATP by oxidative phosphorylation. Besides providing cellular energy, 
mitochondria are involved in multiple cell signalling cascades and the regulation of cellular 
metabolism, development, calcium homeostasis and apoptosis (McBride et al., 2006). 
Therefore, it is not surprising that mitochondrial dysfunctions are linked to ageing and a 
variety of human disorders such as cancer, diabetes and neurodegeneration (Wallace, 2005; 
Chan, 2006). Since mitochondria are the primary producers of reactive oxygen species, 
oxidative damage of mitochondrial proteins or DNA might contribute to mitochondrial 
dysfunctions (Lin and Beal, 2006). To ensure mitochondrial integrity and function, a number 
of control and defense systems have evolved (Tatsuta and Langer, 2008). The first line of 
defense is conducted by an evolutionary conserved proteolytic system which controls the 
quality of mitochondrial proteins and subsequently degrades excess and misfolded proteins 
(Koppen and Langer, 2007). Mitochondrial proteases do not only remove proteins but also 
perform essential housekeeping and regulatory roles during mitochondrial biogenesis by 
processing of proteins.  
 
1.1.1 Processing of mitochondrial proteins 
In human, only 13 polypeptides of in total ~1500 mitochondrial proteins are encoded by 
the mitochondrial genome (Anderson et al., 1981; Lopez et al., 2000). The vast majority is 
encoded by the nuclear genome and synthesized as precursors on cytosolic ribosomes. 
Precursor proteins containing distinct mitochondrial targeting signals are imported into 
mitochondria via different import routes (Bolender et al., 2008). One major import route for 
proteins designated mainly to the matrix, but also to the inner membrane (IM) and the 
intermembrane space (IMS), includes often cleavage of signal sequences by specific 
processing peptidases (Gakh et al., 2002). Many mitochondrial precursors are synthesized 
with a characteristic N-terminal presequence forming a positively charged amphipatic helix. 
The presequence is necessary to target cytosolic precursors to the mitochondria and further 
across both mitochondrial membranes to the matrix where it is cleaved off by the 
mitochondrial processing peptidase MPP (Fig. 1.1) (Hawlitschek et al., 1988). MPP 
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belongs to the zinc-dependent metalloproteases and functions as a heterodimer consisting of 
the conserved subunits α-MPP and β-MPP (Böhni et al., 1983; Yang et al., 1988; Gakh et al., 
2002). A subset of precursor proteins undergoes a second cleavage step in the matrix which is 
mediated by the mitochondrial intermediate peptidase MIP (Fig. 1.1) (Kalousek et al., 
1988; Kalousek et al., 1992). The cleavage by MPP converts precursors into intermediate 
proteins characterized by an N-terminal octapeptide (Isaya et al., 1991; Isaya et al., 1992). 
The mature protein is generated by the subsequent removal of the N-terminal octapeptide 
mediated by the monomeric metalloprotease MIP. The inner membrane peptidase IMP 
mediates the maturation of intermediate forms of several nuclearly encoded proteins 
generated by MPP, as well as mitochondrially encoded subunit 2 of cytochrome c oxidase 
(Fig. 1.1) (Daum et al., 1982; Pratje et al., 1983; Nunnari et al., 1993; Burri et al., 2005). In 
the yeast Saccharomyces cerevisiae, the IMP complex consists of Som1 and the two catalytic 
subunits Imp1 and Imp2 and faces the intermembrane space (Nunnari et al., 1993; Jan et al., 
2000). The catalytic domains of Imp1 and Imp2 are characterized by conserved dyads of 
serine/lysine residues but interestingly display non-overlapping substrate specificities. 
Potential substrates in mammals include the protein Smac/Diablo which functions in 
apoptosis (Burri et al., 2005).  
Other mitochondrial proteases have also been implicated in the maturation of newly 
imported mitochondrial proteins. In S. cerevisiae, the presequence of the mitochondrially 
encoded subunit Atp6 of the F1FO-ATP synthase complex is cleaved off by the 
metallopeptidase Atp23 in the IMS (Fig. 1.1) (Osman et al., 2007; Zeng et al., 2007). 
Independent of its proteolytic activity, Atp23 acts as a chaperone protein and promotes the 
assembly of Atp6 into the membrane-embedded FO-moiety of the ATP synthase complex 
(Osman et al., 2007; Zeng et al., 2007). Cytochrome c peroxidase (Ccp1), a haeme-binding 
ROS scavenger in the IMS of yeast, is processed in two successive steps to its mature form 
during mitochondrial import (Esser et al., 2002). This processing is performed by the 
subsequent action of two inner membrane proteases, the m-AAA protease (discussed later) 
and the rhomboid protease Pcp1 (Esser et al., 2002; Tatsuta et al., 2007). Rhomboid proteases 
comprise a conserved family of intramembrane cleaving peptidases characterised by a 
catalytic serine dyad (Lemberg et al., 2005). Besides Ccp1 maturation, Pcp1 is involved in the 
processing of the dynamin-related GTPase Mgm1, a protein of the mitochondrial fusion 
machinery (Herlan et al., 2003; McQuibban et al., 2003; Sesaki et al., 2003). At steady state, 
Mgm1 exists in a long isoform produced by MPP cleavage, and a short isoform which is 
generated by Pcp1 cleavage. Since the presence of the short Mgm1 isoform is required for 
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mitochondrial fusion, Pcp1-mediated processing of Mgm1 affects mitochondrial morphology 
(Herlan et al., 2003; Herlan et al., 2004). 
 
 
 
 
 
 
 
Figure 1.1 The proteolytic system of mitochondria. 
Processing and protein quality control of proteins residing in the matrix (M), the inner membrane (IM) and the 
intermembrane space (IMS) are key functions of mitochondrial proteases. Proteases involved in protein quality 
control do not only degrade proteins to peptides but also can act as processing enzymes. Recent evidence links 
the cytosolic proteasome to mitochondrial quality control and the regulation of mitochondrial dynamics. Red 
lines represent mitochondrial targeting signals. See text for further details (Figure modified from Koppen and 
Langer, 2007). 
 
 
The mammalian Pcp1 homologue PARL (presenilin-associated rhomboid like protease) 
can functionally substitute for Pcp1 (McQuibban et al., 2003). Although PARL was found to 
physically interact with OPA1, the mammalian orthologue of Mgm1, the deletion of PARL in 
mouse has no obvious effect on mitochondrial morphology (Cipolat et al., 2006). 
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Consistently, only a small fraction of OPA1 appears to be processed by PARL (Cipolat et al., 
2006; Duvezin-Caubet et al., 2007). However, PARL was implicated in controlling apoptosis 
in an OPA1-dependent manner (Cipolat et al., 2006). It should be noted that cleavage of 
OPA1 has also been linked to two AAA-proteases, the i- and the m-AAA protease, residing in 
the inner mitochondrial membrane (Ishihara et al., 2006; Griparic et al., 2007; Song et al., 
2007).  
 
 
 
1.1.2 Quality control of mitochondrial proteins 
Non-assembled and damaged proteins in mitochondria are recognized and degraded by a 
highly elaborate proteolytic system (Koppen and Langer, 2007; Tatsuta and Langer, 2008). 
Different ATP-dependent proteases with chaperone-like functions have been implicated in the 
quality control of mitochondrial proteins. They are characterized by a structurally conserved 
ATPase domain and assemble into multimeric protein complexes with a central proteolytic 
chamber (Sauer et al., 2004; Hanson and Whiteheart, 2005). ATP-binding and -hydrolysis 
induce conformational changes which are required to unfold and deliver substrates into the 
proteolytic chamber (Baker and Sauer, 2006). 
Two different ATP-dependent proteases have been identified in the mitochondrial matrix, 
the Lon (in yeast PIM1 protease) and the ClpXP protease (Suzuki et al., 1994; Van Dyck 
et al., 1994; Wang et al., 1994; De Sagarra et al., 1999). Besides the requirement of 
mitochondrial ClpXP in the unfolded protein response, not much is known about its role 
within mitochondria (Zhao et al., 2002; Haynes et al., 2007). Lon has been demonstrated to 
mediate the proteolysis of misfolded and unassembled matrix proteins (Fig. 1.1) (Bota and 
Davies, 2002; Major et al., 2006). This serine protease forms soluble heptameric complexes in 
the mitochondrial matrix (Stahlberg et al., 1999). Under oxidative stress, Lon is involved in 
the removal of damaged proteins including oxidized proteins, and thereby presumably 
prevents the extensive accumulation of protein aggregates (Bota and Davies, 2002; Bota et 
al., 2005). Besides its role in protein quality control, deletion mutants in yeast indicate an 
essential function of Lon in mtDNA maintenance (Suzuki et al., 1994; Van Dyck et al., 
1994). This is substantiated by the evolutionary conserved ability of Lon to bind DNA 
(Zehnbauer et al., 1981; Fu and Markovitz, 1998; Lu et al., 2003; Liu et al., 2004). 
Furthermore, the human Lon protease was found to be associated with mtDNA under 
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physiological conditions, however, the exact molecular function of this protease in mtDNA 
quality control is not clear yet (Lu et al., 2007).  
Protein quality control in the inner membrane is of special importance. The inner 
membrane harbours the multimeric respiratory chain complexes, which are the main producer 
of reactive oxygen species (ROS) in the cell but also the prime target for oxidative damage. 
Two ATP-dependent proteases with overlapping substrate specificities, the i-AAA and the 
m-AAA protease, are responsible for degrading damaged and non-assembled proteins in the 
inner mitochondrial membrane (Fig. 1.1) (Langer, 2000; Koppen and Langer, 2007). Whereas 
the i-AAA protease exposes its catalytic side to the intermembrane space, the m-AAA 
protease is active on the matrix side. Their function and properties are discussed in detail 
below (Chapter 1.2).  
In contrast to matrix and inner membrane protein degradation, little is known about 
turnover of proteins localised to the intermembrane space and the outer membrane of 
mitochondria. A putative candidate for the surveillance of protein quality in the IMS is 
HtrA2/Omi, a member of a conserved family of serine proteases (Fig. 1.1). Its E. coli 
homologue DegP is a key factor dealing with protein folding stress via its dual functions in 
protein refolding and degradation (Spiess et al., 1999; Clausen et al., 2002). In mammals, 
HtrA2/Omi is upregulated in response to several stress stimuli (Faccio et al., 2000; Gray 
et al., 2000). In contradiction to a potential protective role, several reports proposed 
HtrA2/Omi to promote cell death (Suzuki et al., 2001; Hegde et al., 2002; van Loo et al., 
2002; Verhagen et al., 2002). Following apoptotic stimuli, HtrA2/Omi is released from 
mitochondria into the cytosol where it facilitates apoptosis by its protease activity. However, 
the discussed pro-apoptotic function of HtrA2/Omi is not supported by phenotypes of mice 
lacking HtrA2/Omi function (Jones et al., 2003; Martins et al., 2004). These mice exhibit a 
Parkinson-like neurodegenerative disorder which is caused by neuronal cell death indicating 
an essential and protective role of HtrA2/Omi in vivo. Moreover, loss-of-function mutations 
in the gene encoding HtrA2/Omi were recently identified in patients with Parkinson`s disease 
(Strauss et al., 2005). It is still unclear how HtrA2/Omi protects mitochondria from stress, but 
it might prevent the accumulation of misfolded or damaged proteins in mitochondria in a 
manner similar to its E. coli counterpart DegP. Evidence for a processing activity was recently 
provided by the identification of β-amyloid precursor protein APP as a direct cleavage target 
of HtrA2/Omi in mitochondria (Park et al., 2006). 
Several reports indicate a function of the ubiquitin-proteasome pathway in the quality 
control of outer membrane proteins similar to the ER-associated degradation (ERAD). In 
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mammals, a specific ubiquitin ligase, MARCHV/MITOL, integrated into the outer 
mitochondrial membrane is implicated in the ubiquitination of two mitochondrial fission 
protein, Drp1 and Fis1 (Nakamura et al., 2006; Yonashiro et al., 2006; Karbowski et al., 
2007). However, it is currently not clear if this ubiquitination results in protein degradation or 
exerts a regulatory function. A further role of the 26S proteasome in the quality control has 
been proposed for mitochondrial precursor proteins in the cytosol prior to their import 
(Margineantu et al., 2007; Radke et al., 2008). Several proteomic studies have identified 
ubiquitin-modified proteins that finally reside in different mitochondrial subcompartments, 
suggesting that non-imported proteins are substrates of the ubiquitin-proteasome pathway 
(Peng et al., 2003; Matsumoto et al., 2005; Jeon et al., 2007).  
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1.2 AAA proteases in the inner mitochondrial membrane 
 
1.2.1 Domain structure and assembly of AAA proteases  
AAA proteases form a conserved subclass of ATP-dependent proteases 
(AAA+ proteases) (Langer et al., 2001; Sauer et al., 2004). They are membrane-embedded 
metallopeptidases which are ubiquitously present in eubacteria as well as in chloroplasts and 
mitochondria of eukaryotic cells (Juhola et al., 2000). Two AAA protease complexes are 
integrated into the mitochondrial inner membrane exposing their catalytic sites to opposite 
membrane surfaces: the i-AAA protease exposing its catalytic side to the intermembrane 
space and the m-AAA protease which is active on the matrix side (Fig. 1.2 B) (Arlt et al., 
1996; Leonhard et al., 1996; Weber et al., 1996; Arlt et al., 1998). They form large complexes 
which are composed of either closely related or identical subunits of 70-80 kDa (Atorino 
et al., 2003; Urantowka et al., 2005; Koppen et al., 2007). Whereas the i-AAA protease is a 
homo-oligomeric complex consisting of identical subunits, m-AAA proteases also assemble 
into hetero-oligomeric complexes of highly homologous subunits.  
Mitochondrial localisation of AAA protease subunits is ensured by mitochondrial 
targeting sequences. Subunits of the i-AAA protease are anchored to the mitochondrial inner 
membrane by one transmembrane segment, whereas m-AAA protease subunits contain two 
membrane-spanning domains at their N-terminal ends (Fig.1.2 A) (Arlt et al., 1996; Weber 
et al., 1996). A highly conserved AAA domain identifies them as members of the 
AAA+ superfamily of P-loop ATPases (Sauer et al., 2004; Hanson and Whiteheart, 2005). 
The AAA domain harbours the Walker A (or P-loop) and the Walker B motifs which are 
required for ATP binding and hydrolysis, respectively (Fig.1.2 A). A conserved region 
C-terminal to the Walker B motif, the second region of homology (SRH), defines the AAA 
proteases as members of the AAA-family. The second region of homology contains two 
conserved arginine residues which protrude into the catalytic sites of the neighbouring 
subunits (Hanson and Whiteheart, 2005). These residues are suggested to coordinate 
intermolecular conformational changes during ATPase cycles, thereby stimulating ATP 
hydrolysis. Consequently, oligomerization of AAA protein subunits is necessary for their 
ATPase activity (Akiyama and Ito, 2000; Akiyama and Ito, 2001). The proteolytic domain 
contains the metal binding sequence HEXGH (X represents a variable amino acid residue), a 
sequence motif which is conserved in the M41 family of metallopeptidases (Rawlings and 
Barrett, 1995). Whereas the two histidine residues coordinate a Zn2+-metal ion, the glutamate 
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activates a water molecule for nucleophilic attack of the peptide bond (Hooper, 1994). 
Notably, mutation of the glutamate residue abolishes proteolytic activity whereas substrate 
binding still occurs (Guélin et al., 1994; Arlt et al., 1996; Leonhard et al., 1996; Arlt et al., 
1998).  
 
 
 
 
 
 
Figure 1.2 Mitochondrial AAA proteases. 
(A) Domain structure of AAA proteases. The N-terminal mitochondrial targeting sequence (MTS) is cleaved off 
during import into mitochondria. AAA proteases are integrated into the inner membrane with one or two 
transmembrane segments (TM), respectively. Conserved sequence motifs are displayed in grey. ND, N-terminal 
domain; AAA, AAA domain; PD, proteolytic domain; NH, N-terminal helices; WA, Walker A-motif; WB, 
Walker B-motif; SRH, second region of homology, HEXGH, proteolytic center; CH, C-terminal helices. 
(B) Topology of AAA proteases in the mitochondrial inner membrane (IM). Catalytic domains of the i-AAA and 
the m-AAA protease are located in the intermembrane space (IMS) and the matrix (M), respectively. AAA 
protease subunits share a common domain structure. The stoichiometry and arrangement of the subunits are 
speculative (Figure from Koppen and Langer, 2007). 
 
 
 
Based on crystal structures of the homologous bacterial FtsH protease, a hexameric ring-
like assembly of AAA proteases is proposed which consists of two structurally separated rings 
composed of the proteolytic and the AAA domains, respectively (Bieniossek et al., 2006; 
Suno et al., 2006). The AAA domains facing the membrane form a narrow central pore which 
allows substrates to enter the proteolytic chamber inside the complex. The mitochondrial 
AAA proteases recognize misfolded, solvent-exposed domains of substrates, loops of multi-
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spanning membrane proteins or short terminal protein tails protruding from the membrane 
bilayer (Leonhard et al., 1999). The involvement of the i-AAA or the m-AAA protease in the 
degradation of a protein appears to depend on its membrane topology. Further determinants 
for substrate specificity based on the chaperone-like properties of AAA proteases were 
recently identified in the i-AAA protease of yeast: the C-terminal helices-region (CH-region) 
within the proteolytic domain and the N-terminal helices-region (NH-region) which is part of 
the AAA domain (Graef et al., 2007). They form helical structures and, according to the 
available crystal structure of FtsH from Thermotoga maritima, are located at the surface of the 
catalytic domain (Bieniossek et al., 2006). This positions them ideally for an initial encounter 
with substrate proteins. Translocation of substrates into the proteolytic chamber was shown to 
depend on a conserved loop motif which is located in the AAA domain of other hexameric 
AAA+-proteins and protrudes into the central chamber (Wang et al., 2001; Graef and Langer, 
2006).  
 
 
 
1.2.2 Protein quality control by AAA proteases  
The mitochondrial inner membrane harbours the respiratory chain complexes which are 
essential for cellular function. The assembly of the respiratory chain complexes depends on 
the coordinated expression and oligomerization of nuclear- and mitochondrial-encoded 
subunits. A quality control system is present to ensure that these complexes assemble properly 
and that unassembled subunits do not accumulate. To avoid defects caused by an 
accumulation of unassembled or misfolded proteins in the inner membrane, these proteins 
must be efficiently recognized, extracted from the membrane and degraded by the 
mitochondrial AAA proteases (Fig. 1.3 A) (Langer, 2000; Koppen and Langer, 2007).  
The functions of AAA proteases in mitochondria are best characterized in the yeast 
Saccharomyces cerevisiae. Here, all observed defects associated with deletion of the i- or the 
m-AAA protease can be attributed to a loss of proteolytic activity as point mutations in the 
proteolytic sites result in the same phenotypes (Arlt et al., 1996; Leonhard et al., 1996; Weber 
et al., 1996). In yeast, the homo-oligomeric i-AAA protease is composed of Yme1 subunits 
whereas the hetero-oligomeric m-AAA protease complex consists of the highly related 
subunits Yta10 (Afg3) and Yta12 (Rca1) (Arlt et al., 1996; Leonhard et al., 1996). The 
m-AAA protease was shown to degrade a number of non-assembeld mitochondrially encoded 
respiratory chain subunits of Complex II, IV and V and a peripheral membrane subunit of 
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Complex V, Atp7 (Arlt et al., 1996; Korbel et al., 2004). Deletion of the m-AAA protease in 
yeast results in respiratory deficiency due to the loss of assembled respiratory chain and F1FO-
ATP synthase complexes (Arlt et al., 1998; Galluhn and Langer, 2004). So far, only a few 
quality control substrates of the i-AAA protease have been identified. These include the non-
assembled integral membrane proteins cytochrome c oxidase subunit 2 (Cox2), prohibitin 1 
and prohibitin 2 as well as the soluble NADH dehydrogenase (Nde1) (Pearce and Sherman, 
1995; Weber et al., 1996; Kambacheld et al., 2005).  
 
 
 
 
 
 
Figure 1.3 Functions of AAA proteases in mitochondria. 
(A) Protein quality control of inner membrane proteins. AAA proteases degrade non-assembled and damaged 
proteins to peptides after their dislocation from the membrane. (B) ATP-dependent membrane dislocation of 
proteins. The m-AAA protease mediates the vectorial dislocation of Ccp1 precursor protein independent of its 
proteolytic function followed by Pcp1-mediated intramembrane cleavage. (C) Protein import into mitochondria. 
Import of mammalian PNPase into yeast mitochondria is dependent on the i-AAA protease. (D) Protein 
processing. The mitochondrial targeting sequence of yeast MrpL32 precursor is cleaved during import by the 
m-AAA protease to obtain mature MrpL32. OM, outer mitochondrial membrane; IMS, intermembrane space; 
IM, inner membrane; M, matrix; TOM, translocase of the outer membrane; TIM, translocase of the inner 
membrane; MTS, mitochondrial targeting sequence (Figure modified from Koppen and Langer, 2007). 
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Recently, non-proteolytic functions of AAA proteases have been identified in yeast. The 
maturation of cytochrome c peroxidase (Ccp1), a ROS-scavenger in the intermembrane space, 
is performed by two successive processing steps. During import, the bipartite targeting 
sequence of the Ccp1 precursor is removed by the dual actions of the m-AAA protease and 
the rhomboid protease Pcp1 (Esser et al., 2002). Surprisingly, cleavage by Pcp1 is dependent 
solely on the ATP-dependent membrane dislocation of Ccp1 by the m-AAA protease but not 
on its proteolytic activity (Fig. 3.1 B) (Tatsuta et al., 2007). Thus, the m-AAA protease is 
suggested to ensure the correct positioning of Ccp1 in the membrane allowing intramembrane 
cleavage by Pcp1. Notably, a mammalian homologue of the ROS-scavenger Ccp1 does not 
exist.  
A similar non-proteolytic role has been suggested for the i-AAA protease during import 
of polynucleotide phosphorylase (PNPase) (Rainey et al., 2006). PNPase contains an 
N-terminal targeting signal that is cleaved off by MPP in the matrix followed by translocation 
of mature PNPase into the IMS. Import of mammalian PNPase into yeast mitochondria was 
shown to depend on the presence of the i-AAA protease subunit Yme1 (Fig. 3.1 C). However, 
PNPase is neither processed nor degraded by the i-AAA protease suggesting a non-proteolytic 
function of Yme1 in the translocation of PNPase across the inner membrane. 
 
 
 
1.2.3 Processing functions of AAA proteases 
ATP-dependent proteases do not only function in cellular protein quality control by 
degrading misfolded proteins to peptides (Sauer et al., 2004; Ciechanover, 2005; Hanson and 
Whiteheart, 2005). Moreover, they were shown to activate regulatory proteins with crucial 
cellular functions by proteolytic processing (Rape and Jentsch, 2004). This is exemplified by 
the cytosolic protein degradation machinery, the 26S proteasome, which partially degrades 
several transcription factors and thereby regulates gene expression (Palombella et al., 1994; 
Sasaki et al., 1999; Hoppe et al., 2000). The mechanism how the complete proteolysis of 
proteins is prevented is currently not fully understood. Increasing evidence suggest that the 
folding state determines the fate of substrates bound by energy-dependent proteases (Piwko 
and Jentsch, 2006). To be degraded completely, the substrate must be unfolded in an ATP-
dependent manner before entering the proteolytic cavity (Sauer et al., 2004). Simple sequence 
stretches which precede a tightly folded domain may limit the unfolding capacity and result in 
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the dissociation of a processed substrate from the protease (Kenniston et al., 2005; Tian et al., 
2005; Hoyt et al., 2006). 
Recently, usage of a proteolytic-inactive variant of the m-AAA protease as a substrate 
trap in yeast led to the identification of MrpL32, a subunit of the large ribosome particle in 
mitochondria (Grohmann et al., 1991; Nolden et al., 2005). The m-AAA protease mediates 
the proteolytic maturation of nuclear-encoded MrpL32 upon import into mitochondria (Fig. 
1.3 D) (Nolden et al., 2005). Processing of MrpL32 is necessary for its assembly into 
ribosomes (Fig. 1.4). Mitochondrial ribosomes lacking MrpL32 are functionally inactive and 
therefore mitochondrial translation is drastically impaired in the absence of the m-AAA 
protease. As essential subunits of the respiratory chain complexes are encoded in the 
mitochondrial genome, the lack of respiratory chain complexes in m-AAA protease-deficient 
yeast cells can solely be attributed to an impaired processing of MrpL32.  
 
 
 
 
 
 
 
Figure 1.4 Processing of MrpL32 by the m-AAA protease. 
The m-AAA protease cleaves off the N-terminal mitochondrial targeting sequence of MrpL32 precursor in the 
mitochondrial matrix. Processing of MrpL32 is most likely accompanied by a conformational change which 
allows the assembly of MrpL32 with pre-assembled mitochondrial ribosomes in close proximity to the inner 
membrane. OM, outer membrane; IMS, intermembrane space; IM, inner membrane; M, matrix; TOM, 
translocase of the outer membrane; TIM translocase of the inner membrane; OXA1, membrane insertion 
machinery containing Oxa1 (Figure from Koppen and Langer, 2007). 
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Downregulation of the i-AAA protease in mammalian cells using RNA interference 
identified the mitochondrial fusion component OPA1 as a putative substrate whose processing 
is affected by the i-AAA protease (Griparic et al., 2007; Song et al., 2007). OPA1 is present 
in different isoforms which besides alternative splicing are produced by proteolytic processing 
at two different cleavage sites. Cleavage at one of the processing sites is dependent on the 
i-AAA protease. However, whether the i-AAA protease directly cleaves OPA1 in a site-
specific manner is not clear yet.  
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1.3 Mammalian m-AAA proteases 
 
AAA proteases are conserved from yeast to mammals and share a high sequence identity 
(Fig. 1.5). Functional conservation of the i-AAA and the m-AAA protease was demonstrated 
by complementation studies in yeast (Shah et al., 2000; Atorino et al., 2003; Nolden et al., 
2005). A functional homologue of the i-AAA protease subunit Yme1 was identified in 
humans and mice, named Yme1l1 (Yme1-like gene 1) (Coppola et al., 2000; Shah et al., 
2000). Three potential subunits of the m-AAA protease were found in mice: the two 
homologues subunits Afg3l1 (AFG3-like gene 1) and Afg3l2 (AFG3-like gene 2) with a 
sequence identity of 70% and additionally the subunit paraplegin (Casari et al., 1998; Shah 
et al., 1998; Banfi et al., 1999). Notably, AFG3L1 is not expressed in humans and exists only 
as a pseudogene so that the human m-AAA protease is composed of AFG3L2 and paraplegin 
subunits (Kremmidiotis et al., 2001).  
 
 
 
 
Figure 1.5 Phylogenetic relationships among mitochondrial AAA metalloproteases.  
(A) Phylogenetic tree of the i-AAA and the m-AAA protease subunits. Multiple alignments of mitochondrial 
AAA protease subunits in yeast (Yta10, Yta12 and Yme1), mice (mAfg3l1, mAfg3l2, mparaplegin, mYme1l1) 
and human (hAFG3L2, hParaplegin, hYME1L1) were used to create a phylogenetic tree 
(www.ebi.ac.uk/Tools/clustalw2); Matrix: Gonnet 250. Sequence identities are indiciated in percent. 
(B) Pairwise identity comparison of yeast (Yta10, Yta12) and murine m-AAA protease subunits (Afg3l1, Afg3l2, 
paraplegin). 
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The m-AAA protease assembles with prohibitins into a large supercomplex in yeast and 
mammals (Steglich et al., 1999; Metodiev, 2005). Prohibitins are multimeric complexes 
embedded in the mitochondrial inner membrane composed of the highly conserved subunits 
prohibitin 1 (Phb1) and prohibitin 2 (Phb2) (Steglich et al., 1999; Nijtmans et al., 2000; Artal-
Sanz et al., 2003). Deletion of prohibitins in yeast results in accelerated protein degradation 
by the m-AAA protease suggesting a regulatory function of prohibitins for the m-AAA 
protease (Steglich et al., 1999; Metodiev, 2005). However, neither the molecular mechanism 
of this regulation is clear nor if this regulatory function of prohibitins is conserved in 
mammals.  
 
 
 
1.3.1 Variable subunit composition of m-AAA protease complexes 
Initial complementation studies identified the mammalian hetero-oligomeric complex of 
Afg3l2 and paraplegin as the functional orthologue of the yeast m-AAA protease (Atorino 
et al., 2003; Nolden et al., 2005). Interestingly, recent evidence indicates that, unlike their 
yeast counterparts, mammalian Afg3l2 as well as Afg3l1 are able to form homo-oligomeric 
complexes upon expression in yeast cells (Koppen et al., 2007). Furthermore, these homo-
oligomeric complexes exert proteolytic activity in yeast mitochondria and could substitute for 
the function of the yeast m-AAA protease (Koppen et al., 2007). However, no evidence was 
obtained for the ability of paraplegin to homo-oligomerize (Koppen et al., 2007). It was only 
found to assemble as part of hetero-oligomeric m-AAA protease complexes together with 
Afg3l1, Afg3l2 or both. The different homo- and hetero-oligomeric m-AAA protease 
complexes restored the respiratory growth in yeast cells lacking Yta10 and Yta12 because of 
their ability to process MrpL32 (Koppen et al., 2007). This suggests that mammalian m-AAA 
protease complexes with variable subunit composition can exert housekeeping functions and 
functionally substitute for the yeast m-AAA protease. Co-immunprecipitation and 
immunodepletion studies in human and murine mitochondria provided evidence for the 
existence of different m-AAA protease complexes in vivo (Fig. 1.6) (Koppen et al., 2007).  
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Figure 1.6 Mammalian m-AAA protease isoenzymes with variable subunit composition. 
Immunodepletion and co-immunopreciptation experiments in mammalian mitochondria together with yeast 
complementation studies suggest the existence of at least five different m-AAA protease isoenzymes. The 
presence of a complex consisting of murine paraplegin, Afg3l1 and Afg3l2 is speculative. In human, only two 
AAA protease isoenzymes exist consisting of either paraplegin and AFG3L2 or AFG3L2 alone (Figure from 
Koppen and Langer, 2007). 
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1.3.2 The m-AAA protease paraplegin is involved in the 
 neurodegenerative disease hereditary spastic paraplegia (HSP) 
First insights into the role of mammalian m-AAA protease were obtained by the 
involvement of paraplegin gene (SPG7) mutations in the neurodegenerative disease hereditary 
spastic paraplegia (HSP) (Casari et al., 1998). Neurodegenerative diseases are characterized 
by the progressive loss of a specific subset of neurons. Mitochondrial functions are 
particularly important in the nervous system and essential for versatile neuronal processes 
(Milakovic and Johnson, 2005; Lin and Beal, 2006; Manczak et al., 2006). Many common 
neurodegenerative disorders such as Alzheimer`s, Parkinson`s and Huntington`s disease are 
linked to mitochondrial dysfunctions.  
Hereditary spastic paraplegia (HSP) comprises a genetically heterogeneous group of 
neurodegenerative disorders (Fink, 2003; Soderblom and Blackstone, 2006; Depienne et al., 
2007). The major pathological feature is a progressive degeneration of the longest axons in 
the body, those of the corticospinal tracts and, to a lesser extent, the fasiculi gracilis. The 
axonal degeneration starts from the synaptic terminal and progresses towards the cells body. 
According to the patient`s symptoms, the disease is classified into “pure” and “complicated” 
forms. Besides progressive spasticity and weakness in the lower limbs, complicated forms are 
characterized by additional neurological symptoms including ataxia, mental retardation, optic 
atrophy, dementia and retinopathy (Harding, 1983).  
So far, disease-associated mutations have been identified in 15 different genes (Depienne 
et al., 2007). Based on known functions of the gene products, two major pathophysiological 
mechanisms have been implicated in autosomal forms of HSP (Fink, 2003; Soderblom and 
Blackstone, 2006). Intracellular trafficking and more particular axonal transport, appears to be 
impaired by mutations in gene products such as spastin (SPG4), atlastin (SPG3A) and kinesin 
heavy chain KIF5A (SPG10) (McDermott et al., 2003; Xia et al., 2003; Evans et al., 2006; 
Sanderson et al., 2006). Mutations in spastin are the most prevalent cause for autosomal forms 
of HSP (Hazan et al., 1999). Spastin was shown to interact with microtubules and promote 
their disassembly (Errico et al., 2002; Evans et al., 2005). Mice lacking spastin display axonal 
swellings associated with accumulations of organelles and cytoskeletal compounds suggesting 
an impairment of axonal transport in vivo (Tarrade et al., 2006).  
Mitochondrial dysfunction is the second molecular mechanism implicated in the 
pathogenesis of HSP. Besides paraplegin, a mutation in the mitochondrial chaperone HSP60 
(SPG13) has been identified in HSP (Casari et al., 1998; Hansen et al.). Recently, two other 
disease-associated proteins, spartin (SPG20) and REEP1 (SPG31), have been localised to 
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mitochondria (Lu et al., 2006; Züchner et al., 2006). Whereas the function of REEP1 in 
mitochondria has not been elucidated yet, spartin was suggested to be involved in 
microtubule-mediated mitochondrial transport further underlining the roles of defective 
intracellular trafficking and mitochondrial integrity in the pathogenesis of HSP.  
Several loss-of-function mutations in the paraplegin gene SPG7 are associated with a 
autosomal-recessive form of HSP complicated by optic, cerebellar and cerebral atrophy 
(Casari et al., 1998; McDermott et al., 2001; Wilkinson et al., 2004). Muscle biopsies from 
severely affected patients revealed defects in mitochondrial oxidative phosphorylation (Casari 
et al., 1998; McDermott et al., 2001). Reduced amounts of assembled complex I which result 
in a mild impairment of Complex I activity could by detected in muscles and fibroblasts 
derived from HSP patients (Wilkinson et al., 2004; Atorino et al., 2003). This might be 
consistent with a chaperone-like function of paraplegin in Complex I assembly (Atorino et al., 
2003).  
 
 
 
1.3.3 Paraplegin-deficient mice as a model for HSP  
To further analyze the molecular mechanisms underlying the axonal degeneration and the 
intriguing tissue specificity, a mouse model for HSP caused by loss-of-function mutations in 
the SPG7 gene was generated by gene targeting (Ferreirinha et al., 2004). Paraplegin-deficient 
mice display a progressive retrograde degeneration of long axons in the spinal cord, thus 
replicating central features of the human disease. At about 4 months of age, they start to 
develop a motor deficit together with the appearance of morphologically abnormal and 
enlarged mitochondria in distal regions of affected axons. Only three months later, first signs 
of axonal swelling were observed followed by axonal degeneration. The swelling of axons 
resulted from an accumulation of neurofilaments and organelles, often observed upon axonal 
transport disturbances. In line with this, retrograde axonal transport was slightly delayed in 
17-month-old paraplegin-deficient mice (Ferreirinha et al., 2004).  
The occurrence of the mitochondrial phenotype together with the motor deficit several 
months prior to axonal degeneration suggests that mitochondrial dysfunction is the primary 
cause for the axonal defect. However, besides mitochondrial morphological abnormalities, 
key mitochondrial functions, such as respiratory chain activity and ATP synthesis are not 
significantly impaired in spinal cords of 17-month-old Spg7-/--mice (Ferreirinha et al., 2004). 
Only in spinal cords of 23-month-old Spg7-/--mice a minor defect in ATP synthesis could be 
observed. Nevertheless, it should be emphasized that only a subset of mitochondria is affected 
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in specific neurons of the spinal cord and therefore represents only a minor fraction. Thus, 
only biochemical analysis of paraplegin-deficient mitochondria from affected axons and 
synapses might clarify a putative role of respiratory chain dysfunction in the pathogenesis of 
HSP.  
So far, the primary defect in paraplegin-deficient mitochondria causative for the axonal 
degeneration is not clear. The yeast m-AAA protease degrades a number of non-assembled 
respiratory chain subunits (Arlt et al., 1996; Korbel et al., 2004). Thus, an accumulation of 
non-assembled inner membrane proteins might cause the pathology of HSP associated with 
mutations in paraplegin. A similar mechanism was proposed for HSP caused by mutations in 
the mitochondrial chaperonin Hsp60 (Hansen et al., 2002). However, this hypothesis 
contradicts that protein aggregates have never been detected upon inactivation of m-AAA 
proteases. 
 New insights into potential molecular events that cause HSP might be provided by the 
recent identification of the m-AAA protease-dependent processing of the ribosomal subunit 
MrpL32 in yeast (Claypool and Koehler, 2005; Nolden et al., 2005; Rugarli and Langer, 
2006). A high sequence conservation of MrpL32 and m-AAA protease subunits as well as 
successful complementation studies in yeast indicate a conserved mechanism which regulates 
mitochondrial protein synthesis (Nolden et al., 2005). Reconstitution of the mammalian 
m-AAA protease in yeast provided direct evidence for the ability to cleave murine Mrpl32 
(Nolden et al., 2005). It remains to be answered, if a mitochondrial translation defect caused 
by an impaired Mrpl32 maturation is the underlying mechanism for the axonal degeneration 
in SPG7-linked HSP. The neuron-specific phenotype of HSP seems to be difficult to reconcile 
with a mitochondrial translation defect, a housekeeping function in mitochondria. However, 
variable clinical phenotypes with mitochondrial dysfunction in different tissues have been 
observed in patients who carry mutations in mitochondrial DNA affecting mitochondrial 
protein synthesis (Jacobs, 2003; Jacobs and Turnbull, 2005; Taylor and Turnbull, 2005). 
Tissue-specific phenotypes might be rationalized by different sensitivities of various cells for 
mitochondrial dysfunction (Rossignol et al., 2003). Tissues with a high energy demand like 
brain, muscle and heart are known to be vulnerable to an impairment of mitochondrial 
functions. Besides Mrpl32, the existence of additional tissue-specific substrates of m-AAA 
proteases can be envisioned which contribute to the axonal degeneration in HSP. 
Recently, mice which carry deletions or homozygous mutations in the gene coding for 
the m-AAA protease subunit Afg3l2 have been described (Maltecca et al., 2008). These mice 
die at postnatal day 16 and exhibit a severe defect in axonal development characterized by 
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delayed myelination and impairment of axonal radial growth in the central and peripheral 
nervous system (Maltecca et al., 2008). Swollen and giant mitochondria with disrupted cristae 
membranes are detected in motor and sensory neurons (Maltecca et al., 2008). Furthermore, 
the enzymatic activities of Complex I and III were found to be impaired in brain and spinal 
cord mitochondria isolated from Afg3l2 mutant mice (Maltecca et al., 2008). Thus, the 
neuron-specific phenotypes of paraplegin-deficient and Afg3l2 mutant mice reveal crucial 
functions of the  m-AAA protease in neuronal mitochondria. 
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1.4 Mitochondrial dynamics 
 
Mitochondria are highly dynamic organelles in eukaryotic cells which move along 
cytoskeletal tracks and constantly change their shape by frequent fusion and fission events 
(Chan, 2006; Boldogh and Pon, 2007; Hoppins et al., 2007). Maintenance of mitochondrial 
morphology in cells at steady-state is secured by a balance between fusion and fission events 
(Okamoto and Shaw, 2005). When mitochondrial fusion is reduced, mitochondria fragment 
due to ongoing fission (Fig. 1.7). Conversely, shifting the balance towards mitochondrial 
fusion results in elongated and highly interconnected mitochondria (Fig. 1.7). The control of 
mitochondrial shape is required for correct segregation and distribution of mitochondria. In 
addition, fission and fusion are also important for maintaining the bioenergetic function of 
mitochondria (Chan, 2006; Detmer and Chan, 2007). Therefore, mitochondrial dynamics have 
key roles in mammalian development, several neurodegenerative diseases and apoptosis.  
 
 
 
 
 
 
 
Figure 1.7 Mitochondrial dynamics. 
Mitochondrial morphology is determined by the balance between fusion and fission events. In wt MEFs 
mitochondria form tubules of variable length (central panel). Shifting the balance towards fusion by either 
inhibition of fission and/or activation of fusion results in elongated and highly interconnected mitochondria 
(right panel). Conversely, when mitochondrial fission is induced and/or fusion is blocked, mitochondria 
fragment (left panel).  
 
 
 
Mitochondrial fusion mainly plays a protective role by allowing the mixing of 
mitochondrial contents such as mtDNA molecules and presumably lipids, proteins and 
metabolites (Legros et al., 2004; Detmer and Chan, 2007). Disruption of mitochondrial fusion 
in fibroblasts results in poor cell growth, a widespread heterogeneity of mitochondrial 
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membrane potential and decreased cellular respiration (Chen et al., 2005). The dependency of 
mitochondrial respiration on fusion was shown to be caused by the loss of mtDNA nucleoids 
in the majority of fragmented mitochondria (Chen et al., 2007). These nucleoid-deficient 
mitochondria lack essential respiratory subunits encoded by mtDNA and have no pathway for 
regaining either the requisite proteins or mtDNA. In fusion-competent cells defective 
mitochondria might retrieve essential components by fusion with functional mitochondria. 
This molecular exchange ensures that cells maintain a functional mitochondrial network with 
respiratory activity (Chen et al., 2005; Chen et al., 2007).  
Disruption of mitochondrial fission in C. elegans results in embryonic lethality pointing 
also to an essential function of fission in cellular development (Labrousse et al., 1999). In 
mammals, mitochondrial fission has been shown to be important for mitochondrial 
inheritance and distribution of mitochondria throughout the cell (Warren and Wickner, 1996; 
Hoppins et al., 2007; Knott et al., 2008). In addition, mitochondrial fission facilitates 
apoptosis (Suen et al., 2008). A delay or reduction in apoptosis is observed when 
mitochondrial fragmentation is blocked (Suen et al., 2008). Conversely, mitochondrial 
fragmentation in response to stress might also protect cells from apoptosis by sequestering 
damaged mitochondria from the intact mitochondrial network (Kim et al., 2007; Tatsuta and 
Langer, 2008). Consequently, dysfunctional and fragmented mitochondria can be eliminated 
by autophagy before apoptosis is induced through the mitochondrial pathway.  
The mitochondrial fusion and fission machineries have been best characterized in 
S. cerevisae (Hoppins et al., 2007). In mammals, orthologues of most fusion and fission 
proteins exist indicating that the mechanisms of mitochondrial membrane fusion and fission 
are highly conserved (Chan, 2006). Several large dynamin-related GTPases which are 
essential for mitochondrial dynamics have been identified. Dynamin-1 (Dnm1) in yeast and 
its mammalian homologue dynamin-related protein (Drp1) are targeted to the mitochondrial 
outer membrane to promote mitochondrial fission (Otsuga et al., 1998; Smirnova et al., 
2001). Mitochondrial fusion requires components of the outer and inner mitochondrial 
membrane (Hoppins et al., 2007). Studies in yeast identified the proteins Fzo1 and Mgm1 as 
mediators of outer and inner membrane fusion, respectively (Hermann et al., 1998; Sesaki 
et al., 2003; Wong et al., 2003; Meeusen et al., 2006). The mammalian orthologues of Fzo1 
are mitofusin 1 and 2 (Mfn1 and 2) (Fig. 1.8 A) (Santel and Fuller, 2001; Legros et al., 2002). 
OPA1 (Optic atrophy 1) is the functional homologue of Mgm1 in mammals (Fig. 1.8 A) 
(Alexander et al., 2000; Delettre et al., 2000; Olichon et al., 2003).  
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Intriguingly, inherited loss-of-function mutations of MFN2 or OPA1 cause progressive 
neuropathies in humans. MFN2 mutations lead to Charcot-Marie-Tooth Type 2A (CMT2A), a 
peripheral neuropathy characterized by loss of motor and sensory neurons (Züchner and 
Vance, 2005). Mutations in OPA1 result in autosomal dominant optic atrophy (ADOA) 
characterized by degeneration of retinal ganglion cells (Alexander et al., 2000; Delettre et al., 
2000). Thus, a loss of mitochondrial fusion proteins and the consequent continuous fission 
appear to play a causal role in the initiation of neurodegeneration (Knott et al., 2008). 
 
 
 
1.4.1 Outer mitochondrial membrane fusion 
Mfn1 and Mfn2 are anchored to the outer mitochondrial membrane by a bipartite 
transmembrane region (Fig. 1.8 A) (Rojo et al., 2002). The N- and C-terminal regions 
protrude into the cytosol (Fig. 1.8 B). Besides a large GTPase domain, they harbour two 
characteristic hydrophobic heptad repeat regions which are predicted to form helical coiled-
coil structures (Fig. 1.8 A). Through interactions of their coiled-coil structures the mitofusins 
are proposed to form hetero- and homo-oligomeric structures in trans and thereby tether outer 
membranes of adjacent mitochondria (Fig. 1.8 B) (Chen et al., 2003; Ishihara et al., 2004; 
Koshiba et al., 2004). Cells lacking either Mfn1 or Mfn2 show greatly reduced mitochondrial 
fusion and consequently mitochondria are highly fragmented (Chen et al., 2003; Eura et al., 
2003; Chen et al., 2005). However, only in the absence of both mitofusins, mitochondrial 
fusion is completely abolished resulting in not only severely fragmented mitochondria but 
also reduced respiratory capacity (Chen et al., 2005). Thus, Mfn1 and Mfn2 seem to have 
similar functions in mitochondrial fusion and can functionally replace each other when 
overexpressed (Detmer and Chan, 2007). Nevertheless, loss of either Mfn1 or Mfn2 leads to 
distinct phenotypes on the cellular level as well as in mouse models (Chen et al., 2003; Eura 
et al., 2003; Chen et al., 2005; Chen et al., 2007). These distinct phenotypes can be explained 
by tissue-specific differences in their expression levels (Detmer and Chan, 2007). Moreover, 
several observations point to different properties of Mfn1 and Mfn2. First, OPA1-mediated 
mitochondrial fusion is only dependent on Mfn1 but not on Mfn2 (Cipolat et al., 2004). 
Second, an in vitro mitochondrial tethering assay revealed a higher tethering activity for Mfn1 
than for Mfn2 (Ishihara et al., 2004). 
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Figure 1.8 Mitochondrial fusion proteins. 
(A) Schematic structure of mitochondrial GTPases involved in mitochondrial fusion in mammals and the yeast 
S. cerevisiae. These proteins contain a GTPase domain (GTPase) and hydrophobic heptad repeats. Mitofusins 
(Mfn1/Mfn2) and Fzo1 also contain a bipartite transmembrane domain (TM). OPA1/Mgm1 contains an 
N-terminal mitochondrial targeting sequence (MTS) followed by two putative transmembrane domains. The 
middle domain and the GTPase effector domain (GED) are characteristic for dynamin familiy members. 
(B) Mitochondrial tethering by Mfn1. Mfn1 is integrated into the outer membrane by its bipartite transmembrane 
region. Most of Mfn1 is exposed to the cytosol. Intermolecular interactions between Mfn1 proteins on opposing 
mitochondria are mediated by the C-terminal heptad repeat regions and result in tethering of mitochondrial outer 
membranes (OM). Inner membrane, IM. (modified from Chan et al., 2006). 
 
 
 
1.4.2 Inner mitochondrial membrane fusion  
The dynamin-related protein OPA1, which is mainly localized at the inner mitochondrial 
membrane, is a further essential component of the mitochondrial fusion machinery in 
mammals (Olichon et al., 2003; Chan, 2006; Duvezin-Caubet et al., 2006; Ishihara et al., 
2006). OPA1 harbours an N-terminal mitochondrial targeting sequence (MTS) which is 
cleaved upon mitochondrial import by the mitochondrial processing peptidase (MPP) (Misaka 
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et al., 2002; Olichon et al., 2002). The MTS is followed by short hydrophobic stretches and a 
coiled-coil domain located directly in front of the GTPase domain (Fig. 1.8 A). A middle 
domain and a further coiled-coil domain known as GTPase effector domain (GED) are present 
at the C-terminus of OPA1 (Fig. 1.8 A).  
OPA1 is encoded by a single gene which gives rise to eight splice variants resulting from 
alternative splicing of the exons 4, 4b and 5b (Delettre et al., 2001). The OPA1 gene is 
ubiquitiously expressed with the highest levels in the retina, brain and muscle (Alexander 
et al., 2000). Notably, differences in the relative abundance of each OPA1 splice variants in 
various tissues have been observed (Delettre et al., 2001; Olichon et al., 2006). Several long 
and short protein OPA1 isoforms are produced by a combination of alternative splicing and 
post-translational proteolytic processing (Duvezin-Caubet et al., 2006; Ishihara et al., 2006). 
Whereas long OPA1 isoforms are anchored to the inner membrane, short isoforms are only 
peripherally associated with it (Duvezin-Caubet et al., 2006; Ishihara et al., 2006). Fusion 
assays in mammalian cells have demonstrated the requirement of both, the short and long 
isoforms for mitochondrial fusion (Song et al., 2007). In vitro studies of mitochondrial fusion 
in yeast revealed that the orthologue of OPA1, Mgm1, is required for inner membrane fusion, 
whereas strikingly outer membrane fusion can still occur in the absence of Mgm1 (Meeusen 
et al., 2006). Similar to the mitofusins, Mgm1 seems to interact with itself in trans to tether 
inner mitochondrial membranes (Meeusen et al., 2006).  
Downregulation of OPA1 in MEFs does not only block mitochondrial fusion resulting in 
fragmentation of mitochondria (Olichon et al., 2003; Cipolat et al., 2004; Lee et al., 2004). 
Furthermore, mitochondrial fragmentation is accompanied by defects in mitochondrial 
respiration, highly disorganized cristae in the inner membrane and an increased susceptibility 
to apoptosis (Olichon et al., 2003; Griparic et al., 2004; Lee et al., 2004; Frezza et al., 2006). 
Evidence exists that OPA1 has functions in mitochondria which might not be linked to 
mitochondrial fusion. Recent observations indicate that OPA1 might regulate cristae 
remodelling during apoptosis via oligomeric self-assembly independent of fusion (Frezza 
et al., 2006). Moreover, large mtDNA deletions were detected in skeletal muscles of human 
patients with OPA1-linked dominant optic atrophy, thus, pointing to a function of OPA1 in 
mtDNA maintenance (Amati-Bonneau et al., 2008; Hudson et al., 2008).  
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1.4.3 Coordination of inner and outer membrane fusion 
Analysis of mitochondrial fusion events in vivo by time-lapse fluorescence microscopy 
indicates that outer and inner membrane fusion events are temporarily linked. However, 
manipulations of mitochondrial fusion in vitro and in vivo have demonstrated that they can 
proceed separately and have different requirements (Meeusen et al., 2004; Malka et al., 
2005). Dissipation of the mitochondrial membrane potential in mammalian cells selectively 
inhibits inner membrane fusion but not outer membrane fusion (Malka et al., 2005). 
Interestingly, outer membrane fusion is directly followed by fission which results in the 
overall mitochondrial fragmentation observed upon dissipation of the membrane potential 
(Sesaki et al., 2003; Malka et al., 2005). This indicates that inner membrane fusion might be 
necessary for outer membrane fusion to occur in vivo. However, it is still unclear how these 
distinct and separate fusion machineries are coupled to each other to temporarily link inner 
and outer mitochondrial fusion events. In S. cerevisiae, a third protein, Ugo1, is part of the 
mitochondrial fusion machinery (Sesaki and Jensen, 2001). The outer membrane protein 
Ugo1 has been found to bind Mgm1 and Fzo1, thereby linking inner and outer membrane 
fusion proteins (Wong et al., 2003; Sesaki and Jensen, 2004). Therefore, this two 
membrane-spanning complex formed by Ugo1 might play a role in coordinating inner and 
outer membrane fusion events in yeast. However, no mammalian homologues of Ugo1 have 
been identified so far. 
 
 
 
1.4.4 Regulation of mitochondrial morphology by proteolytic processing 
 of OPA1 
Both OPA1 and its yeast orthologue Mgm1 undergo extensive proteolytic processing 
which controls mitochondrial fusion activity (Herlan et al., 2003; McQuibban et al., 2003; 
Duvezin-Caubet et al., 2006; Ishihara et al., 2006; Griparic et al., 2007; Song et al., 2007). In 
contrast to OPA1, processing of Mgm1 in yeast is well characterized and less complex. 
Mgm1 exists as a long and a short isoform, l-Mgm1 and s-Mgm1, respectively. L-Mgm1 is 
produced by MPP cleavage of the Mgm1 precursor and is integrated into the inner 
mitochondrial membrane by the first of its two hydrophobic segments (Fig. 1.9) (Herlan et al., 
2003). Alternatively, l-Mgm1 can be further pulled into the matrix until the second 
hydrophobic region is anchored to the inner membrane (Fig. 1.9). Subsequently, the 
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mitochondrial rhomboid protease Pcp1 cleaves Mgm1 at a second processing site to produce 
s-Mgm1 (Herlan et al., 2003; McQuibban et al., 2003). Formation of s-Mgm1 depends on the 
protein import motor machinery and on high ATP levels in the matrix (Herlan et al., 2004). 
Both l-Mgm1 and s-Mgm1 are necessary for mitochondrial fusion (Herlan et al., 2003). The 
deletion of Pcp1 results in the absence of s-Mgm1 and consequently, in loss of mitochondrial 
fusion activity.  
 
 
 
 
 
 
 
Figure 1.9 Processing of Mgm1 by the rhomboid protease Pcp1. 
Newly synthesized Mgm1 precursor (pMgm1) is processed to the long form of Mgm1 (l-Mgm1) by the 
mitochondrial processing peptidase (MPP) during import into mitochondria and integrated into the inner 
membrane. Alternatively, l-Mgm1 is cleaved by Pcp1 to generate the short form of Mgm1 (s-Mgm1). Pcp1 
cleavage depends on the mitochondrial membrane potential (ΔΨ), matrix ATP and a functional import motor 
(PAM). OM, outer membrane; IMS, intermembrane space; IM, inner membrane; M, matrix. (Figure from 
Koppen and Langer, 2007). 
 
 
 
Similar to Mgm1, a balance of short and long OPA1 isoforms is required for 
mitochondrial fusion activity in mammals (Song et al., 2007). At least five OPA1 isoforms 
can be detected in mammals resulting from alternative splicing and proteolytic processing 
(Delettre et al., 2001; Duvezin-Caubet et al., 2006; Ishihara et al., 2006). They consist of two 
large OPA1-isoforms, L1 and L2, anchored to the inner membrane and three short isoforms, 
S3-S5, which are only loosely attached to the membrane (Duvezin-Caubet et al., 2006). Long 
OPA1 forms can be processed constitutively at two different cleavage sites, S1 and S2, which 
are located N-terminal of the GTPase domain (Ishihara et al., 2006; Duvezin-Caubet et al., 
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2007). Recently, the i-AAA protease Yme1l1 was identified to be involved in cleavage at site 
S2 (Griparic et al., 2007; Song et al., 2007). However, the physiological consequences of this 
cleavage are still unclear. Cleavage at site S1 can be induced upon dissipation of the 
membrane potential (Duvezin-Caubet et al., 2006; Ishihara et al., 2006; Song et al., 2007). 
This results in a fast conversion of long OPA1 into small OPA1 isoforms accompanied by 
simultaneous fragmentation of mitochondria. So far, the responsible protease regulating 
mitochondrial morphology by cleavage at site S1 has not been clearly identified. 
Nevertheless, besides Yme1l1 two additional proteases have been implicated in processing of 
OPA1. 
The mammalian ortholgoue of Pcp1, PARL can functionally replace Pcp1 in yeast cells 
and mediate the processing of Mgm1 (McQuibban et al., 2003). The physical interaction of 
PARL and OPA1, as demonstrated by co-immunopreciptitation studies support a role of 
PARL in processing of OPA1 (Cipolat et al., 2006). Indeed, the generation of a soluble form 
of OPA1 was shown to be dependent on PARL (Cipolat et al., 2006). However, this 
represents only a very minor fraction of OPA1 and the pattern of OPA1 isoforms is not 
significantly altered in PARL-deficient cells (Cipolat et al., 2006; Duvezin-Caubet et al., 
2007). Consistently, PARL-deficient cells display a mitochondrial morphology similar to wt 
cells. Furthermore, PARL does not process OPA1 when they are co-expressed in yeast 
(Duvezin-Caubet et al., 2007). 
The m-AAA protease subunit paraplegin has also been implicated in processing of OPA1 
at site S1 (Ishihara et al., 2006). However, OPA1 processing is not affected in paraplegin-
deficient cells (Duvezin-Caubet et al., 2007). Since other mammalian m-AAA protease 
subunits form functional m-AAA protease complexes, they might substitute for paraplegin in 
regard to processing of OPA1 (Koppen et al., 2007). Indeed, co-expression of OPA1 with 
m-AAA isoenzymes in yeast revealed that OPA1 can be cleaved by the mammalian m-AAA 
protease (Duvezin-Caubet et al., 2007).  
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1.5 Aims of the thesis 
 
Mammalian m-AAA proteases are composed of the subunits Afg3l1, Afg3l2 and 
paraplegin. Loss-of-function mutations in the subunit paraplegin are linked to the 
neurodegenerative disease hereditary spastic paraplegia (HSP). However, the molecular 
mechanisms which result in the tissue-specific axonal degeneration of HSP patients lacking 
paraplegin remain to be elucidated. The identification of the ribosomal subunit MrpL32 as a 
substrate for the m-AAA protease in yeast points to a link of HSP to defective mitochondrial 
protein synthesis. Thus, the first part of this thesis aimed at analyzing the conservation of the 
m-AAA protease-dependent processing of Mrpl32 in mammals. The usage of paraplegin-
deficient mice which recapitulate major features of HSP allowed to further examine the role 
of this putative function in the pathogenesis of HSP.  
In contrast to paraplegin which exists only in hetero-oligomeric m-AAA protease 
complexes, Afg3l1 and Afg3l2 have the ability to build up functional homo-oligomers. 
Therefore, in paraplegin-deficient mice functionally active m-AAA proteases consisting of 
Afg3l1 and Afg3l2 are still present and can compensate for the loss of paraplegin. To provide 
further insights into functions of mammalian m-AAA proteases on a cellular level, single 
subunits or combinations of subunits were transiently downregulated in MEFs using RNA 
interference. Reconstitution experiments in yeast revealed the ability of mammalian m-AAA 
protease complexes to directly cleave OPA1, a component of the mitochondrial fusion 
machinery. Notably, other mitochondrial proteases have also been implicated in the 
processing of OPA1. Thus, this approach might help to clarify the role of m-AAA isoenzymes 
in the processing of OPA1 in vivo. 
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2 Materials and Methods 
 
2.1 Molecular Biology Methods 
 
Standard methods in molecular biology were performed according to protocols published 
in (Sambrook and Russell, 2001). Enzymes used were purchased from NEB (New England 
Biolabs). Chemicals were purchased form Sigma or Merck unless stated otherwise.  
 
 
 
2.1.1 Expression plasmids and cloning of pGEM4-Mrpl32 
The cDNA of Mrpl32 was amplified by PCR from murine cDNA using the primers 
5´CGGGGTACCATGGCTCCTTCGTTGCTGCTGCTTTC-3´ (TL2226) and 3´-GCTCTAG-
ATTCAATTCTGGGTGAACCAAGATGGCCTC-5´ (TL2227). The purified PCR fragment 
was subcloned in pGEM-T easy (Promega) and finally cloned in the KpnI-XbaI restriction 
sites of pGEM4 (Promega). The DNA sequence was verified with the ABI Big Dye 
Terminator Sequencing Kit (Applied Biosystem) and the ABI Prism 3730 DNA analyzer 
(Applied Biosystem). 
 
 
Table 2.1 Expression plasmids 
Plasmid Reference 
pGEM-T easy-Mrpl32 This study  
pGEM4-Mrpl32 This study  
pSV40 (Benoist and Chambon, 
1981) 
pDsRed2-mito Clontech 
p3xFlag-CMV14  (Ishihara et al., 2006) 
p3xFlag-CMV14-rat Opa1 splice variant 1 (Ishihara et al., 2006) 
p3xFlag-CMV14-rat OPA1 splice variant 1ΔS1 (Ishihara et al., 2006) 
p3xFlag-CMV14-rat OPA1 splice variant 7 (Ishihara et al., 2006) 
p3xFlag-CMV14-rat OPA1 splice variant 7ΔS1 (Ishihara et al., 2006) 
p3xFlag-CMV14-rat AIF(1-95)-OPA1 sp7 (230-997) (Ishihara et al., 2006) 
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2.1.2 RNA isolation  
Total RNA from was extracted from mouse liver using the RNeasy Midi Kit (Qiagen) 
according to the manufacturer´s instructions. Briefly, 200 mg mouse liver were homogenized 
in 4 ml lysis buffer using a rotor-stator homogenizer. The RNA was eluted in 300 µl RNase-
free water. Total RNA concentrations were determined spectrophotometrically at a 
wavelength of 260 nm. To increase the RNA concentration, RNA was precipitated and 
resuspended in RNase-free water to obtain a final concentration of 1 µg/µl. 
 
 
 
2.1.3 Northern Blot and RNA hybridization  
10 µg total RNA were size-fractionated on a 1.2% (w/v) agarose/1.5% (v/v) 
formaldehyde gel and transferred to positively charged nylon membranes (HybondTM-N+, 
Amersham Biosciences) by capillary transfer with 20x SSC (3 M NaCl, 0.3 M sodium citrate, 
pH 7.0). RNA was crosslinked to membranes using UV-light. 75 ng of each cDNA probe 
were radioactively labeled with [α32P]-dCTP (Amersham) by random priming using the 
LaddermanTM Labeling Kit (Takara). Non-incorporated radiolabeled nucleotides were 
removed with MicroSpinTM S-200HR columns (Amersham). Before adding the probes to the 
hybridization solution, they were denatured for 5 min at 95 °C. Nylon membranes were 
prehybridized in hybridization solution (Express Hyb, Stratagene) supplemented with 
100 µg/ml sonicated salmon sperm DNA for 2 hrs at 50°C. Hybridization of the probe was 
performed in hybridization solution (Express Hyb, Stratagene) at 50°C overnight. Hybridized 
blots were washed three times with 2x SSC/0.05% (w/v) SDS at RT followed by two 
washings for 15 min at 50°C with 0.1x SSC/0.1% (w/v) SDS. To detect radioactive signals, 
membranes were exposed to X-ray films (BioMAX MS, Eastman Kodak) at -80°C overnight 
or to a phosphoimager screen (Fuji) followed by detection (Molecular Imager, BioRad) and 
quantificitation (Quantity One; BioRad) of the phosphorence signals. To remove radioactive 
probes from membranes, they were incubated in 1% (w/v) SDS at 95°C for 10 min. 
DNA probes for β-actin, mitochondrially encoded NADH dehydrogenase subunit 1 (mt-
Nd1) and cytochrome c oxidase subunit 2 (mt-Cox2) were synthesized from C57BL/6 mouse 
genomic DNA using the primers listed in Table 2.2. To generate the probe for Mrpl32, the 
cDNA of Mrpl32 was excised with the restriction enzymes XbaI and KpnI from pGEM-
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Teasy-Mrpl32 and purified by agarose gel extraction (NucleoSpin® Extract II; Macherey-
Nagel). 
 
 
Table 2.2 Primers for DNA probe synthesis 
Description  Sequence  
5´-β-actin (TL1813) 5´-CAGAAGGAGATTACTGCTCTGGCT -3´ 
3´-β-actin (TL1814) 3´-AGGAGCCACCGATCCACACA-5´ 
5´-Nd1 (TL2597) 5´-CGACCTGACAGAAGGAGAAT-3´ 
3´-Nd1 (TL2598) 3´-GTAACGGAAGCGTGGATAAG-5 
5´-Cox2  (TL2593) 5´-GGCACCAATGATACTGAAGC-3´ 
3´-Cox2  (TL2594) 3´-AGTGGAGGACGTCTTCAGAT-5´ 
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2.2 Cell Biology Methods  
 
2.2.1 Cell culture 
Human HeLa cells (ATCC) were cultured in high-glucose Eagle´s Minimum Essential 
Medium (EMEM, PAA) supplemented with 10% (v/v) fetal bovine serum (FBS, Invitrogen). 
Cell lines derived from mouse embryonic fibroblasts (MEFs) were cultured in Dulbecco´s 
Minimum Essential Medium (DMEM, Invitrogen) supplemented with 10% (v/v) FBS. 
Additionally, 2 mM L-glutamine (PAA), 100 U/ml penicillin (PAA), 100 µg/ml streptomycin 
(PAA), 100 µM non-essential amino acids (PAA) and 1 mM sodium pyruvate (PAA) were 
added if necessary. Cells were cultured at 37°C/5% CO2 and 90% humidity.  
For cryofreezing of cells, they were harvested with 1x trypsin (PAA) and centrifuged at 
800g for 5 min. The cell pellet was resupended in cold freezing medium consisting of 
90% FBS (v/v)/10% (v/v) DMSO and slowly frozen to -80°C. For long-term storage, cells 
were placed in liquid nitrogen (-200°C) after a few days. 
Primary mouse embryo fibroblasts were established from E14.5 embryos derived from 
intercrosses of time-mated Spg7+/+ or Spg7-/--mice. Early passages of primary MEFs were 
immortalised by SV40 transformation (Todaro and Green, 1965). 
 
 
Table 2.3 Cell lines used in this study 
Cell line Description Reference  
Phb2fl/fl  SV40-immortalized MEF cell line  (Merkwirth et al., 2008) 
HeLa Human cervix cancer cell line  ATCC® No. CCL-2  
Spg7+/+ and Spg7-/- SV40-immortalized MEF cell line This study 
Parl+/+ and Parl-/- SV40-immortalized MEF cell line  (Cipolat et al., 2006) 
Htra2+/+  and Htra2-/-  SV40-immortalized MEF cell line (Martins et al., 2004) 
 
 
 
2.2.2 Transfections  
RNAi-mediated knockdown of genes was performed using specific Stealth™ RNAi 
(Invitrogen) listed in Table 2.4 and 2.5. The corresponding Stealth™ RNAi Negative Control 
(Invitrogen, 12935-100) served to exclude sequence-independent effects of RNAi delivery in 
cell lines. One day before transfection, 6-8x104 cells were plated in each well of a 6 well-plate 
in medium without antibiotics. 10-20 nM of each siRNA were transfected with 
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Lipofectamine™ RNAiMAX Transfection Reagent (Invitrogen) according to the 
manufacturer´s instructions. After 48-72 hrs of transfection, cells were harvested and further 
analyzed.  
Transient transfection of cells with plasmid DNA was carried out using GeneJuice 
transfection reagent (Novagen) according to the manufacturer´s instructions. 
 
 
Table 2.4 List of siRNAs directed against murine mRNA 
Target mRNA Accession nr. siRNA Sequence  
Paraplegin NM_153176  5´-GCGCGUCAUUGCUGGUACUGCUAAA-3´  
Afg3l2 NM_027130 5´-CCUGCCUCCGUACGCUCUAUCAAUA-3´  
Afg3l1 NM_054070  5´-GCGAAACCAUGGUGGAGAAGCCAUA-3´ 
Yme1l1 NM_013771  5´-UUCAGUUCGACCCUUCACAUCUGGC-3´ 
Yme1l1 NM_013771  5´-AACAAUUUGAAUCUCUUUGGCAUCC-3´ 
Lon NM_028782     5´-CCACACAAGGCAAGAUCCUCUGCUU-3´  
Lon NM_028782     5´-UGUGAUGAAAGAGAGUGCCCGCAUA-3´  
Phb2 NM_007531 5´-AUUAACAAUGGACGGCAGCACUCGC-3´ 
OPA1 NM_133752  5´-CAAGAGCAGUGUGUUCACAACGAAA-3´ 
 
 
Table 2.5 List of siRNAs directed against human mRNA 
Target mRNA Accession nr. Sequence  
AFG3L2 NM_006796 5´-GGUAUUGGAGAAACCUUACAGUGAA-3´ 
Paraplegin NM_003119 5´-GGAAGUCCGCGAGUUUGUGGAUUAU-3´ 
 
 
 
2.2.3 Fluorescence microscopy 
To analyze mitochondrial morphology, MEFs were transfected with pDsRed2-mito 
(Clontech). At least one day before transfection, cells were seeded on cover slips in 6-well 
plates. 24-48 hrs after transfection, proteins were fixed with 3% (w/v) Paraformaldehyde in 
1x PBS (PAA) for 15 min at 37°C and rinsed twice with 1x PBS. To visualize nuclear DNA, 
cells were incubated for 5 min at 37°C in 1 µg/µl DAPI (Roche) in 1x PBS. Afterwards, 
specimens were washed twice with 1x PBS and mounted in ProLong® Gold Antifade 
Reagent (Molecular Probes). Fluorescently labeled mitochondria were examined using the 
DeltaVision microscope system and the Softworx software (Applied precision). Images were 
deconvolved and further edited using CORELDRAW™ 11 Graphics Suite software (Corel 
Corporation).  
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2.2.4 Fluorescence-activated cell sorting (FACS) 
 
2.2.4.1  Membrane potential measurement  
Mitochondrial membrane potential of cells was measured 48 hrs after siRNA transfection 
using the lipophilic, cationic dye JC-1 (Molecular Probes) as recommended by the 
manufacturer. Briefly, 2x105 were resuspended in 500 µl growth medium and incubated at 
37°C with 2 µM JC-1 for 15 min. As a negative control, 20 µM CCCP was added to dissipate 
mitochondrial membrane potential. After incubation, cells were washed and resuspended in 
1x PBS. Analysis of JC-1 fluorescence was examined with excitation at 488 nm and emission 
at 535 nm and 590 nm on a FACSCalibur equipped with CellQuest software (Becton 
Dickinson). 
 
2.2.4.2 Measurement of reactive oxygen species  
Three days after transfection with specific siRNAs, 2.5*105 MEFs were harvested and 
resuspended in 500 µl growth medium without phenolred containing 1 µM carboxy-
H2DFCDA (Molecular Probes) and further incubated a 37°C for 15 min. Addition of 10 or 
20 µM antimycin A induced reactive oxygen species (ROS) production. After incubation, 
cells were washed and resuspended in 1x PBS. Analysis of the oxidation-sensitive H2DFCDA 
fluorescence was examined with excitation at 488 nm and emission at 535 nm. on a FACS 
Calibur equipped with CellQuest software (Becton Dickinson). Propidiumiodide (10 µg/ml) 
was added 1 min before flow cytometry 
 
 
 
2.2.5 Oxygen consumption measurements in intact cells 
Respiration of intact cells was measured at 37°C with a Clark-tape electrode oxygraph 
(Hansatech Inc.) in a water-jacketed chamber connected to a circulating water bath. The 
chamber volumes were set to 500 µl. 2.5x106 cells were assayed in 250 mM saccharose, 
20 mM HEPES pH7,4, 10 mM KH2PO4, 4 mM MgCl2, 1 mM EDTA, 5 mM glucose, 2 mM 
pyruvate and 4 mM glutamate. The measurement started with recording the routine 
endogenous respiration. After observing steady state respiratory flux, ATP synthase was 
inhibited with 2 µM oligomycin for 5 min. This was followed by uncoupling of oxidative 
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phosphorylation using stepwise titration of CCCP with concentrations in the range of 250-
750 nM. After 5 min recording, cellular respiration was inhibited with 2 mM KCN and was 
corrected to KCN-insensitive respiration. The respiratory control ratio was obtained dividing 
the rates of oxygen consumption achieved after and before the addition of CCCP.  
 
 
 
2.2.6 Protease inhibitor studies 
To inhibit specific classes of proteases, MEFs were incubated with different membrane-
soluble protease inhibitors three days after co-transfection of plasmid DNA and siRNA. The 
following protease inhibitors were diluted in growth medium: 5 µM MG132 (Serva), 0.5 mM 
o-phenantroline (Sigma), 50 µM Pepstatin A (Serva), 0.5 mM Pefabloc SC (Roth) and 50 µM 
E-64 (Serva). To inhibit cytosolic protein synthesis, 100 µg/ml cycloheximide (CHX; Sigma) 
were added 30 min later. After 5 hrs of protease inhibition, MEFs were harvested, lysed in 
RIPA-buffer (Chapter 2.3.1) and further analyzed by SDS-PAGE and immunoblotting. 
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2.3 Biochemical methods 
 
2.3.1 Preparation of protein extracts  
Cells were trypsinized and washed once with 1x PBS (PAA). After incubation of the 
cells in RIPA buffer at 4°C for 1 hr, lysates were centrifuged for 20 min at 16.000g to remove 
unsolubilized cell membranes. The protein concentration was determined with a Bradford 
protein assay (BioRad) using IgG as standard and cell lysates were diluted with RIPA buffer 
to a final protein concentration of 10 µg/µl.  
 
RIPA buffer 
1 mM Tris-HCl, pH 7.4 
150 mM NaCl 
1% (v/v) Triton X-100 
0.5% (w/v) Sodiumdeoxycholate 
0.1% (w/v) SDS 
1 mM EDTA 
1 mM PMSF 
Complete Mini Protease Inhibitor Cocktail Mix (Roche) 
 
 
 
2.3.2 SDS-PAGE and immunoblotting 
Proteins (50-150 µg) were size-fractionated with SDS-PAGE and transferred to 
nitrocellulose membranes (Immobilon-P; Millipore) according to established protocols 
(Laemmli, 1970; Towbin et al., 1979). After transfer of proteins, membranes were incubated 
for at least 30 min at RT in blocking solution (5% (w/v) milkpowder in 1x TBS (10 mM 
Tris/HCl, pH 7.4; 150 mM NaCl). Immunodecoration with a specific antiserum diluted in 
blocking solution was carried out for at least 60 min at RT or overnight at 4°C. Nitrocellulose 
membranes were washed three times for 10 min with 1x TBS at RT. To detect bound 
antibodies, horseradish peroxidase-conjugated antibodies specific for immunoglobulin G of 
rabbit, mouse or rat were applied in a dilution of 1:5000-1:10000 in blocking solution for 
60 min. After washing the membranes three times with 1x TBS, the chemiluminesence 
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reagents (Solution 1: 100 mM Tris-HCl, pH 8.5, 250 µM luminol, 400 µM p-coumaric acid; 
Solution 2: 100 mM Tris-HCl, pH 8.5 0.02% (v/v) H202) were added in a mixture of 1:1. 
Chemiluminesence was detected by exposing the membranes to light-sensitive X-ray films 
(Super RX, Fuji).  
 
 
 
Table 2.6 Antibodies used in this study 
Antibody  Antigen  Dilution Reference 
α-Paraplegin Amino acids 121-139 of murine Paraplegin  1:200 
(Koppen et al., 
2007) 
α-AFG3L2 Amino acids 413-828 of human Afg3l2 1:8000 
F. Taroni, 
unpublished 
α-Afg3l2 Amino acids 90-103 of murine Afg3l2  1:200 (Koppen et al., 2007) 
α-Afg3l1 Amino acids 771-785 of murine Afg3l1 1:500 
(Koppen et al., 
2007) 
α-YME1L1 Recombinant human YME1L1 1:500 ProteinTech Group, Inc. 
α-Mrpl32 Amino acids 83-98 of murine Mrpl32 1:500 (Nolden et al., 2005) 
α-TIM23 Amino acids 5-126 of rat TIM23 1:1000 BD Biosciences 
α-CIII, subunit 
IIa 
Purified Core IIa subunit of human 
Complex IIII 1:1000 Molecular Probes 
α-OPA1 Amino acids 708-830 of human OPA1 1:1000 BD Biosciences 
α-CII, 70 kDa 
subunit  
Purified 70 kDa subunit of human 
Complex III 1:5000 Molecular Probes  
α-Flag M2 Synthetic FLAG peptide DYKDDDDK 1:1000 Sigma 
α-BAP37 (PHB2) Recombinant C-terminus of human PHB2 1:500 BioLegend 
α-Aconitase Amino acids 767-780 of human Aconitase 1:1000 
Ngo & Davies,  
unpublished 
α-Porin N-terminal peptide of human porin 1:1000 Calbiochem 
α-Lon 
Amino acids 
KKEFELSKLQQRLGREVEEK of 
human Lon  
1:500 (Liu et al., 2003) 
α-SLP2 Recombinant C-terminus of human SLP2  1:1000 
Genway Biotech 
Inc. 
α-HtrA2 Amino acids 134-458 of human HtrA2 with a C-terminal six histidine tag 1:2000 R&D Systems 
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2.3.3 Isolation of mitochondria from different murine organs 
Liver, brain and spinal cord were dissected from mice, immediately minced and 
homogenized in isolation buffer with 6 strokes in a Teflon-glass pestle. The crude 
homogenate was centrifuged at 1000g for 10 min. To remove fatty acids, the supernatant of 
liver was strained through gauze. Mitochondria were pelleted by centrifugation at 8000g for 
10 min and resuspended in isolation buffer without BSA. Protein concentration was 
determined using the Bradford protein assay (BioRad). 
 
Isolation buffer:  
220 mM D-mannitol 
70 mM sucrose 
20 mM HEPES, pH 7.2 
2 mM EGTA 
0.1% (w/v) BSA 
Complete Mini Protease Inhibitor Cocktail Mix (Roche) 
 
 
 
2.3.4 In vitro import of proteins into isolated mitochondria 
SP6 promoter-driven in vitro transcription of Mrpl32 and subsequent translation in the 
presence of [35S]-labeled methionine (MP Biomedicals) was performed using the 
TNT® Coupled Reticulocyte Lysate System (Promega) according to the manufacturer´s 
instructions.  
For in vitro protein import studies, mitochondria were resuspended in import buffer to a 
final concentration of 1 mg/ml. After 3 min incubation at 30°C, [35S]-labeled precursor 
proteins were added to a final concentration of 2% (v/v) and the samples were further 
incubated at 30°C for various times. The import of mitochondrial proteins was stopped by the 
addition of 0.2 µM valinomycin, 4 µM FCCP and 1 µM oligomycin. To remove non-imported 
precursor proteins, proteinase K (Roche) was added to a final concentration of 75 µg/ml and 
the samples were incubated for 10 min on ice. After addition of 1 mM PMSF to inhibit 
proteinase K activity, mitochondria were washed twice with SHKCl and finally resuspended 
in 1x SDS-sample buffer. The samples were analyzed by SDS-PAGE and autoradiography.  
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Importbuffer     SHKCl 
250 mM sucrose    0.6 M sorbitol 
20 mM HEPES, pH 7.4   50 mM HEPES, pH 7.4 
5 mM magnesium acetate   60 mM KCl 
80 mM potassium acetate 
10 mM sodium succinate 
2.5 mM ADP 
1 mM DTT 
 
 
 
2.3.5 Stability of newly imported, radioactively labeled proteins in 
 isolated mitochondria (import-chase) 
Import of radioactively labeled precursor proteins was performed at 30°C for 15 min as 
described above (Chapter 2.3.4). To stop the import reaction, samples were placed on ice and 
incubated with 100 µg/ml trypsin for 20 min at 4°C to remove non-imported proteins. Trypsin 
was inhibited with 1 µg/µl soy bean trypsin inhibitor (STI) for 5 min on ice. Afterwards, 
samples were incubated at 37°C for up to 30 min to induce degradation of newly-imported 
proteins. Aliquots were withdrawn at each time point and placed on ice. Mitochondria were 
isolated by centrifugation at 13.000g for 10 min at 4°C and washed twice with SHKCl. After 
the last washing step, the mitochondrial pellet was resupended in 15 µl 1x SDS-sample buffer 
and analyzed by SDS-PAGE and autoradiography.  
 
 
 
2.3.6 In organello translation of mitochondrial proteins 
To radioactively label mitochondrially encoded proteins, 1 mg/ml mitochondria were 
incubated at 30°C in translation buffer in the presence of 100 µg/ml cycloheximide. After 
3 min preincubation, 200 µCi/ml [35S]-methionine were added. The translation was stopped 
with 20 mM methionine and the mitochondrial pellet was washed twice with SHKCl before 
proteins were precipitated with 12.5% (w/v) ice-cold TCA. The protein pellet was washed 
twice with acetone (-20°C) and dissolved in 40 µl SDS-sample buffer. Samples were analyzed 
by SDS-PAGE and autoradiography. Incorporated radioactivity was determined by 
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scintillation counting after thourough vortexing of 1 ml scintillation solution (Ultima Gold) 
with 20 µl of each sample. 
 
Translation buffer:  
100 mM mannitol 
80 mM sucrose 
10 mM sodium succinate 
80 mM KCl 
5 mM MgCl2 
1 mM potassium phosphate 
25 mM HEPES pH 7.2 
300 µM of each of the aminoacids except methionine 
5 mM ATP 
20 µM GTP 
6 mM creatine phosphate 
60 µg/ml creatine kinase 
 
 
 
2.3.7 Determination of respiratory chain activity in isolated mitochondria 
Freshly isolated mitochondria were centrifuged at 8000g for 10 min and the resulting 
mitochondrial pellet was resuspended in respiration buffer (250 mM sucrose, 50 mM HEPES 
pH 7.4, 10 mM KH2PO4, 2 mM MgCl2, 1 mM EDTA) to a concentration of 5 mg/ml. 
Polarographic measurements were performed at 30°C with a Clark-tape electrode oxygraph 
(Hansatech Inc.) in a water-jacketed chamber connected to a circulating water bath. State 2 
respiration (basal respiration rate) was measured with 6 mM glutamate/malate or 
pyruvate/malate using 125 µg mitochondria. Measurement of state 3 respiration (maximal 
respiration rate) using 1 µM rotenone/12 mM succinate as substrates was initiated with 1 mM 
ADP and stopped with 2 mM KCN. Respiration rates were calculated as consumption of 
nmol O2/min x mg protein.  
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2.4 Mouse analysis 
 
2.4.1 Animal care 
Care of all animals was within institutional animal care committee guidelines. All animal 
procedures were approved by local government authorities (Bezirksregierung Köln, Germany) 
and performed according to NIH guidelines. General handling and breeding of mice was 
conducted according to established protocols (Hogan B., 1987; Silver, 1995). Mice were 
housed in groups of three to five at 22-24 °C with a 12 hrs light/dark cycle.  
 
 
 
2.4.2 Mice 
Spg7+/+-and Spg7-/--mice used in this study had a mixed C57BL/6-129Sv genetic 
background. Spg7-/--mice were generated by targeting of the first two exons of the Spg7 locus 
by homologous recombination (Ferreirinha et al., 2004). The gene targeting vector contained 
the first two coding exons with the selectable neomycin resistance gene flanked by two loxP 
sites (Ferreirinha et al., 2004). 
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3 Results 
 
3.1 Analysis of mitochondrial dysfunctions in paraplegin-deficient 
 mice  
 
In humans, loss-of-function mutations in paraplegin cause an autosomal recessive form 
of hereditary spastic paraplegia (HSP), a neurodegenerative disorder mainly caused by axonal 
degeneration in central and peripheral nerves (Casari et al., 1998). Recently, a paraplegin-
deficient (Spg7-/-) mouse model for HSP was generated which replicates important features of 
the human disease (Ferreirinha et al., 2004). However, the primary molecular defects which 
result in this neurodegenerative disease remain to be elucidated. Studies of the m-AAA 
protease in yeast revealed new insights into the pathogenesis of HSP by identifying MrpL32, 
a nuclear-encoded protein of the mitochondrial ribosome, as a new substrate of the m-AAA 
protease. Moreover, the proteolytic maturation of MrpL32 by the m-AAA protease was shown 
to be essential for mitochondrial protein synthesis (Nolden et al., 2005). Mrpl32 and m-AAA 
proteases are highly conserved in eukaryotes and functional complementation of the yeast 
m-AAA protease by its murine homologues could be demonstrated (Nolden et al., 2005). 
However, it has not been analyzed yet whether the m-AAA protease-dependent maturation of 
murine Mrpl32 is conserved in vivo and whether this putative function of the m-AAA protease 
subunit paraplegin is causative for the axonal degeneration observed in HSP.  
 
 
 
3.1.1 Reduced steady state levels of Mrpl32 in mitochondria lacking 
 paraplegin  
To investigate whether maturation of Mrpl32 by the m-AAA protease is conserved in 
mammals, protein steady state levels of mature Mrpl32 were analyzed in paraplegin-deficient 
mice. Thus, mitochondria were isolated from liver of Spg7+/+- and Spg7-/--mice and subjected 
to SDS-PAGE. Immunoblotting with a polyclonal antiserum raised against Mrpl32 revealed a 
significantly reduced steady state level of mature Mrpl32 in liver mitochondria lacking 
paraplegin (Fig. 3.1 A). This result might give a first hint to a function of paraplegin in the 
maturation of Mrpl32.  
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To exclude that the reduced steady state level of mature Mrpl32 is caused by impaired 
transcription of the Mrpl32 gene due to secondary effects of paraplegin deficiency, RNA was 
isolated from liver of wt and Spg7-/--mice to perform Northern blot analysis using cDNA 
probes for Mrpl32, and for β-actin as a control. Radioactive signals were quantified and the 
expression level of Mrpl32 relative to β-actin in Spg7-/--mice was compared to wt. No 
reduction in mRNA expression of Mrpl32 in paraplegin-deficient mice compared to wt was 
observed, strongly indicating that the reduced protein steady state level of Mrpl32 is caused 
by posttranscriptional events (Fig. 3.1 B and C). Furthermore, this experiment revealed that 
the expression of the mitochondrial-encoded genes Nd1 and Cox2 in Spg7-/--mice is not 
affected.  
 
 
 
 
 
 
 
Figure 3.1 Reduced steady state level of Mrpl32 in paraplegin-deficient mitochondria. 
(A) Steady state level of Mrpl32 in liver mitochondria lacking paraplegin. Immunoblotting of mitochondria 
isolated from Spg7+/+-and Spg7-/--mice was performed using a Mrpl32-specific antiserum. An antibody 
recognizing subunit 2 of Complex III (CIII) was used as a loading control. (B) Northern blot analysis of Mrpl32 
mRNA expression in liver. Total RNA was isolated from liver of Spg7+/+-and Spg7-/--mice. Northern blot 
analysis was performed using probes recognizing mRNAs of Mrpl32, β-actin, Nd1 and Cox2 followed by 
autoradiography. (C) Quantification of Mrpl32 mRNA expression in liver isolated from paraplegin-deficient 
mice. Phosporescence signals of hybridized probes were quantified. Signals of Mrpl32, Nd1 and Cox2 were 
normalized to β-actin signals and the ratios in wt were set to 100 %.  
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Taken together, a decrease in the steady-state level of mature Mrpl32 was observed in 
paraplegin-deficient liver mitochondria compared to wt while the mRNA level of Mrpl32 was 
not affected. Since reconstitution experiments in yeast provided direct evidence for the ability 
of mammalian m-AAA proteases to cleave murine Mrpl32, it is likely that posttranslational 
defects in the absence of the paraplegin are involved in the decrease of mature Mrpl32 
(Nolden et al., 2005). 
 
 
 
3.1.2 Maturation of Mrpl32 proceeds normally in paraplegin-deficient 
 mice 
Considering the essential function of m-AAA protease-dependent proteolytic processing 
of MrpL32 in yeast (Nolden et al., 2005), reduced protein levels of mature Mrpl32 in 
paraplegin-deficient murine liver mitochondria suggest a role of paraplegin in Mrpl32 
maturation. To get insights into the involvement of paraplegin, the proteolytic maturation of 
Mrpl32 was investigated by in vitro import of precursor Mrpl32 into liver mitochondria 
derived from paraplegin-deficient and wt mice.   
Radioactively labeled precursor protein of Mrpl32 was synthesized in a cell-free system 
and incubated with liver mitochondria isolated from Spg7+/+- and Spg7-/--mice. Mrpl32 was 
imported into wt mitochondria in a membrane potential-dependent manner (Fig. 3.2 A). Upon 
import, the precursor of Mrpl32 was converted in the mature form by proteolytic processing 
and protected against protease treatment indicating successful import into mitochondria. 
However, an impairment in processing of Mrpl32 could not be observed in mitochondria 
lacking paraplegin (Fig. 3.2 B). Remarkably, immunodecoration with α-Mrpl32 antiserum 
revealed an increase in steady state levels of mature Mrpl32 upon import in paraplegin-
deficient mitochondria (Fig. 3.2 B). 
To further examine the function of paraplegin for the accumulation of mature Mrpl32, 
the stability of newly imported Mrpl32 in the absence of paraplegin was investigated. Mrpl32 
precursor protein was imported into liver mitochondria and the degradation of radioactively 
labeled mature Mrpl32 was assessed at 37 °C. However, equal turnover rates of newly 
imported Mrpl32 were observed in wt and paraplegin-deficient mitochondria (Fig. 3.2 C). In 
summary, no defect in Mrpl32 maturation could be observed in paraplegin-deficient liver 
mitochondria in vitro. 
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Figure 3.2 Proteolytic processing of Mrpl32 in paraplegin-deficient mitochondria.  
(A) and (B) Processing of Mrpl32 upon import into mitochondria. Mrpl32 was synthesized in a cell-free system 
in the presence of [35S]-methionine and imported into liver mitochondria isolated from Spg7+/+- (A) and Spg7-/--
mice (B) at 30 °C for up to 30 min. Membrane potential was dissipated by adding valinomycin, FCCP and 
oligomycin prior to import (-Δψ). Non-imported proteins were degraded by proteinase K (PK). Samples were 
analyzed by SDS-PAGE and autoradiography. Immunoblotting was performed using an antiserum directed 
against Mrpl32. (C) Stability of newly imported Mrpl32 in mitochondria. Radioactively labeled Mrpl32 was 
imported into liver mitochondria derived from Spg7+/+- and Spg7-/--mice at 30 °C for 15 min. Non-imported 
proteins were removed by addition of trypsin. Samples were further incubated at 37°C for up to 30 min to allow 
protein degradation to occur. Analysis was conducted by SDS-PAGE and autoradiograpy. Membranes were 
immunodecorated with an antiserum raised against Mrpl32. try, trypsin.  
 
3.1.3 Paraplegin is essential for optimal mitochondrial translation in liver 
In yeast, m-AAA protease-dependent maturation of Mrpl32 is essential for mitochondrial 
translation (Nolden et al., 2005). Defects in the mitochondrial translation machinery in human 
were shown to be the molecular cause for a number of inherited neurodegenerative diseases 
(Miller et al., 2004; Sylvester et al., 2004; Jacobs and Turnbull, 2005; Antonicka et al., 2006). 
Although Mrpl32 processing proceeds normally in isolated liver mitochondria lacking 
paraplegin, it is a crucial point for the pathogenesis of HSP to determine the consequences of 
reduced Mrpl32 steady state levels on mitochondrial protein synthesis.  
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Figure 3.3 Impaired mitochondrial translation in murine liver mitochondria lacking paraplegin.  
Mitochondria from liver (A and B), brain (C and D) and spinal cord (E and F) were isolated from 11-month-old 
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To analyze mitochondrial protein synthesis, mitochondrial translation products were 
labeled in the presence of [35S]-methionine in liver mitochondria isolated from 11-month old 
wt and paraplegin-deficient mice. The kinetics and efficiencies of mitochondrial protein 
synthesis were monitored via SDS-PAGE and autoradiography. Additionally, the 
incorporation of radioactivity into newly synthesized mitochondrial proteins was quantified 
by scintillation counting.  
In the absence of paraplegin, mitochondrial translation was significantly impaired in liver 
mitochondria with a decrease of 50 % compared to wt (Fig. 3.3 A and B). These findings 
provide evidence that an impaired mitochondrial protein synthesis might be linked to axonal 
degeneration in HSP caused by loss of paraplegin. To substantiate these findings, the 
efficiency of mitochondrial translation was analyzed in brain and spinal cord, tissues which 
are mainly affected in Spg7-/--mice (Ferreirinha et al., 2004). Remarkably, no statistically 
significant decrease in mitochondrial protein synthesis could be detected in brain and spinal 
cord of paraplegin-deficient mice (Fig 3.3 C, D and E, F).  
In summary, these findings reveal an important function of paraplegin for mitochondrial 
protein synthesis in liver. However, this function of paraplegin seems to be tissue-specific 
since mitochondrial translation is largely unaffected in brain and spinal cord of paraplegin-
deficient mice. Thus, a defective mitochondrial proteins synthesis seems not to be the 
underlying pathogenic mechanism in HSP. 
 
 
 
 
 
 
 
 
 
 
 
 
wt (filled circles) and Spg7-/--mice (open circles). Mitochondrially encoded proteins were synthesized in the 
presence of [35S]-methionine at 30°C for the indicated time points. (A, C and E) Mitochondrial protein synthesis 
was analyzed by SDS-PAGE and autoradiography. (B, D and F) Efficiency of mitochondrial translation was 
quantified by determining total incorporated radioactivity from seven independent experiments and the statistical 
significance was assessed by paired Student´s t-test. * p<0.05; ** p<0.01. Error bars represent ± standard 
deviation of the mean (SEM). 
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3.1.4 Mitochondrial respiratory function is not affected in paraplegin-
 deficient mice 
The impaired mitochondrial translation detectable in liver prompted us to investigate 
the mitochondrial respiratory functions. Essential respiratory chain subunits are 
mitochondrially encoded. Hence, mitochondrial protein synthesis defects should result in 
impaired respiratory chain activity (Jacobs and Turnbull, 2005). To investigate this, oxygen 
consumption of freshly isolated liver mitochondria was measured in collaboration with 
A. Bernacchia (Istituto Nazionale Neurologico "C. Besta", Milan). The basal respiration rate 
(state 2) was quantified using glutamate/malate, substrates entering the electron transport 
chain at Complex I, whereas ADP-induced maximal respiration rate (state 3) was analyzed 
using succinate, which enters the electron transport chain at Complex II. Strikingly, in liver 
mitochondria lacking paraplegin neither state 2 respiration nor state 3 respiration was 
impaired (Fig. 3.4 A and B). 
 
 
 
 
 
 
 
Figure 3.4 Maintenance of mitochondrial respiration rates in liver, brain and spinal cord of paraplegin-
deficient mice. 
Oxygen consumption rates in isolated mitochondria from liver, brain and spinal cord from 11-month-old 
Spg7+/+- and Spg7-/--mice. (A) State 2 respiration was determined using glutamate/malate (liver) or 
pyruvate/malate (brain and spinal cord) as substrates. (B) Succinate was used to measure ADP-stimulated 
respiration (State 3). Error bars represent ± standard deviations (SD) of seven independent experiments. Sp.c, 
spinal cord. 
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In order to elucidate the role of mitochondrial dysfunction in the pathogenesis of HSP, 
oxygen consumption rates of isolated brain and spinal cord mitochondria were analyzed in 
parallel. Neither state 2 nor state 3 respiration rates were decreased in brain and spinal cord 
mitochondria of Spg7-/--mice (Fig. 3.4 A and B). This is consistent with the previous findings 
of a functional mitochondrial protein synthesis in brain and spinal cord (Fig. 3.3 C-F).  
In summary, respiratory chain activity is generally not affected in mitochondria 
lacking paraplegin suggesting that a dysfunction in mitochondrial respiratory activity is not 
the molecular cause for HSP.  
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3.2 Functional analysis of m-AAA proteases in MEFs using RNA 
 interference  
 
In humans, m-AAA protease complexes are composed of the subunits Paraplegin and 
AFG3L2 (Atorino et al., 2003). An additional subunit of the m-AAA protease, Afg3l1, is 
expressed in mice, which exists only as a pseudogene in human (Kremmidiotis et al., 2001). 
Interestingly, m-AAA protease isoforms with variable subunit compositions have been 
identified recently (Koppen and Langer, 2007). Whereas paraplegin is only present in hetero-
oligomeric complexes, Afg3l2 and Afg3l1 have additionally the ability to homo-oligomerize. 
Yeast complementation studies revealed proteolytic activity of different m-AAA protease 
assemblies. However, the function of m-AAA proteases has never been analyzed in 
mammalian systems besides paraplegin-deficient mice (Spg7-/-). Since in Spg7-/--mice, 
functionally active m-AAA proteases consisting of Afg3l1 and Afg3l2 are still present, they 
can compensate for the loss of paraplegin (Koppen and Langer, 2007). Therefore, the aim was 
to investigate the function of m-AAA proteases and the role of the different subunits in 
mammals. Because knock-out mice for Afg3l1 and Afg3l2 were not available, different 
m-AAA protease subunits were transiently downregulated in mammalian cells using RNA 
interference. 
 
 
3.2.1 Downregulation of m-AAA protease subunits in MEFs using RNA 
 interference 
3.2.1.1 Efficient depletion of single or combinations of m-AAA protease 
subunits 
Transient knockdown of m-AAA protease subunits in MEFs was accomplished using 
Stealth™ RNAi (Invitrogen) directed against specific mRNA sequences. Stealth™ siRNAs 
are chemically modified double-stranded 25-mer RNA oligonucleotide sequences without a 
single-stranded overhang. Such modifications were reported to reduce non-specific off-target 
effects and to confer greater stability to siRNAs (Invitrogen). Specific siRNAs for efficient 
knockdown of different m-AAA proteases were designed using the Stealth™ RNAi design 
algorithm (Invitrogen). Stealth™ RNAi negative controls (Invitrogen) served as control for 
the RNAi response. At least three siRNAs directed against each m-AAA protease subunit 
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were tested for specificity and efficiency in downregulation and one was chosen for 
subsequent experiments.  
Expression of paraplegin, Afg3l1 and Afg3l2 in MEFs was analyzed 48 hrs after double 
transfection with the respective siRNA. Afg3l1, Afg3l2 and paraplegin expression was more 
than 90% reduced on protein level (Fig. 3.5 A). Remarkably, similar knockdown efficiencies 
were achieved when two subunits or even all three m-AAA protease subunits were 
downregulated simultaneously. Additionally, SV40-immortalized MEF cell lines derived 
from Spg7+/+-and Spg7-/--mice were established to benefit from the complete absence of 
paraplegin. After siRNA transfection, the expression of Afg3l1 and Afg3l2, either alone or 
together, was reduced more than 90% on protein level in Spg7+/+- and Spg7-/--MEFs (Fig. 3.5 
B). Notably, downregulation of Afg3l1 and Afg3l2 in MEFs resulted in the appearance of two 
bands which correspond to murine paraplegin. Otherwise, expression of Afg3l1, Afg3l2 and 
paraplegin was not affected upon knockdown of the respective other m-AAA subunits.  
In summary, single or combinations of m-AAA protease subunits can be efficiently and 
specifically downregulated. Therefore, siRNA-mediated knockdown is a useful tool to study 
the function of different m-AAA protease complexes in mammalian cells.   
 
 
 
 
 
 
 
Figure 3.5 Downregulation of m-AAA protease subunits in MEFs. 
Downregulation of Afg3l1, Afg3l2 and paraplegin in wt MEFs (A) and in Spg7+/+ and Spg7-/--MEFs (B). Cells 
were transfected twice with Stealth siRNA directed against Afg3l1, Afg3l2 and paraplegin alone and in different 
combinations. Control cells were transfected twice with negative control siRNA. After 48 hrs, cells were lysed 
and analyzed by SDS-PAGE and immunblotting using specific antisera recognizing paraplegin, Afg3l1, Afg3l2 
and, as a loading control 70 kDa subunit of Complex II (CII). Para, paraplegin; L1, Afg3l1; L2, Afg3l2. 
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3.2.1.2 Overlapping substrate specificities of the murine m-AAA protease 
subunits Afg3l1 and Afg3l2  
The murine m-AAA protease subunits Afg3l1 and Afg3l2 share a high protein sequence 
identity of 70% pointing to similar activities of Afg3l1 and Afg3l2 in mice. The appearance of 
a larger band of paraplegin upon simultaneous knockdown of Afg3l1 and Afg3l2 indicates 
that these m-AAA protease subunits might be both involved in the maturation of paraplegin 
(Fig. 3.5 A and B). To verify the redundant functions of Afg3l1 and Afg3l2 in regard to 
paraplegin maturation, MEFs were transfected with siRNA specific for these m-AAA protease 
subunits. Cell lysates were analyzed by SDS-PAGE and immunoblotting with paraplegin-
specific antiserum. Upon single knockdown of Afg3l1 or Afg3l2 only mature paraplegin was 
present. In contrast, concomitant knockdown of Afg3l1 and Afg3l2 resulted in the appearance 
of a larger band of paraplegin and in the reduction of the steady-state level of mature 
paraplegin (Fig. 3.6 A). These findings suggest that paraplegin is only partially processed to 
its mature form upon downregulation of Afg3l1 and Afg3l2.  
Both, Afg3l1 and Afg3l2 were shown to substitute for the yeast m-AAA protease in the 
processing of yeast MrpL32 (Koppen and Langer, 2007). Therefore, the role of Afg3l1 and 
Afg3l2 in processing of murine Mrpl32 were investigated. Single m-AAA protease subunits 
or different combinations of subunits were downregulated and analyzed by immunoblotting 
using antiserum specific for murine Mrpl32. Upon knockdown of m-AAA proteases in MEFs, 
no significant reduction of mature Mrpl32 could be observed (Fig. 3.6 B). However, 
following depletion of Afg3l1 and Afg3l2 a larger band of Mrpl32 appeared that co-migrated 
with the precursor form of Mrpl32, indicating an impaired processing of Mrpl32. Notably, an 
additional downregulation of paraplegin did not result in an increased accumulation of the 
putative precursor of Mrpl32.  
Remarkably, only AFG3L2 but not AFG3L1 is expressed in human (Kremmidiotis et al., 
2001). Therefore, it was analyzed whether human AFG3L2 exerts the overlapping functions 
of murine Afg3l1 and Afg3l2. Hence, HeLa cells were transfected with siRNA specific for 
human AFG3L2 and Paraplegin. Western blots of cell lysates, decorated with the antibodies 
α-AFG3L2 and α-Paraplegin, revealed efficient downregulation of both proteins in human 
HeLa cells (Fig. 3.6 C). Strikingly, no band specific for Paraplegin could be detected in 
AFG3L2-depleted cells suggesting an increased turnover of paraplegin. In agreement with 
observations in MEFs, knockdown of AFG3L2 resulted in the appearance of the precursor 
form of Mrpl32 without reduction in the steady state level of mature Mrpl32.  
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Taken together, these results identify Mrpl32 and paraplegin as putative substrates of the 
mammalian m-AAA protease. In MEFs, Afg3l1 and Afg3l2 seem both to be involved in the 
maturation of paraplegin and Mrpl32 indicating that they have at least partially overlapping 
substrate specificities.  
 
 
 
 
 
 
 
Figure 3.6 Overlapping substrate specificities of Afg3l1 and Afg3l2 in MEFs. 
(A) and (B) Impaired processing of paraplegin and Mrpl32. Cells were transfected twice with respective siRNAs 
directed against murine m-AAA protease subunits and harvested after 48 hrs.  Control cells were transfected with 
Stealth siRNA negative controls. 48 hrs after transfection, cells were lysed and subjected to SDS-PAGE and 
immunoblotting. (A) Immunoblot analysis of MEFs after knockdown of Afg3l1 and Afg3l2 with specific 
antibodies recognizing paraplegin and the 70 kDa subunit of Complex II (CII). (B) Immunoblot analysis of 
MEFs after knockdown of Afg3l1, Afg3l2 and paraplegin with Mrpl32-specific antiserum. Films developed with 
either a short or a long exposure time are shown (C) Immunoblot analysis of HeLa cells after siRNA-mediated 
downregulation of Paraplegin and AFG3L2. HeLa cells were analyzed as above after siRNA transfection with 
stealth siRNA specific for human AFG3L2 and Paraplegin. Immunoblotting was performed using antisera 
recognizing human paraplegin, AFG3L2, MRPL32 and, as a loading control PHB2. Para, paraplegin; L1, 
Afg3l1; L2, Afg3l2 or AFG3L2; p, precursor; m, mature form. 
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3.2.2 Loss of long OPA1 isoforms in m-AAA protease-depleted MEFs 
 results in mitochondrial fragmentation 
 
 The dynamin-like GTPase OPA1 functions in mitochondrial fusion and inner membrane 
remodelling (Olichon et al., 2003; Cipolat et al., 2004; Griparic et al., 2004). Mutations in the 
human OPA1 gene cause autosomal dominant optic atrophy (ADOA), a prevalent hereditary 
neuropathy of the optic nerve (Alexander et al., 2000; Delettre et al., 2000). At least five 
apparent different OPA1 isoforms have been identified in different tissues and cell lines 
(Delettre et al., 2001; Olichon et al., 2003; Duvezin-Caubet et al., 2006; Ishihara et al., 2006). 
They were shown to result from at least eight different splice variants and proteolytic 
cleavage of large isoforms to small isoforms (Delettre et al., 2001; Olichon et al., 2002; Satoh 
et al., 2003; Ishihara et al., 2006; Duvezin-Caubet et al., 2007). So far, the rhomboid protease 
PARL and the m-AAA protease subunit paraplegin were proposed to be involved in the 
processing of OPA1 (Cipolat et al., 2006; Ishihara et al., 2006). However, no drastic 
differences in the pattern of OPA1 isoforms were observed in cells lacking PARL or 
paraplegin compared to wt (Duvezin-Caubet et al., 2007). Recently, the mitochondrial 
m-AAA subunits Afg3l1 and Afg3l2 were shown to be capable of cleaving OPA1 when 
reconstituted in yeast (Duvezin-Caubet et al., 2007). Thus, the aim of the following 
experiments was to further clarify the role of mammalian m-AAA proteases in the processing 
of OPA1.  
 
 
3.2.2.1 Loss of long OPA1 isoforms in the absence of the m-AAA 
proteases Afg3l1 and Afg3l2 
To investigate the requirement of m-AAA-proteases in OPA1 processing, Afg3l1 and 
Afg3l2 were downregulated in Spg7+/+- and Spg7-/--MEFs and analyzed by immunoblotting 
using α-OPA1 antibodies. As previously published, five OPA1 isoforms could be detected 
corresponding to two long isoforms, L1 and L2, which can be processed to three short 
isoforms, S3-S5 (Fig. 3.7 A) (Duvezin-Caubet et al., 2007). Upon knockdown of either 
Afg3l1 or Afg3l2 in wt and paraplegin-deficient cells, no drastic alterations in the pattern of 
isoforms occurred compared to control cells (Fig. 3.7 A). Strikingly, simultaneous depletion 
of Afg3l1 and Afg3l2 resulted in the loss of the long OPA1 isoforms L1 and L2 whereas the 
short isoforms S5 and, to a lower extent, S3 accumulated (Fig. 3.7 A). The steady-state level 
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of the short isoform S4 was slightly reduced. In contrast to Afg3l1 and Afg3l2, the absence of 
paraplegin in Spg7-/--MEFs did not lead to any changes in the pattern of OPA1 isoforms (Fig. 
3.7 A). Similar results were obtained in human HeLa cells in which downregulation of 
AFG3L2 (see Fig. 3.6 C) resulted as well in a decrease of L-OPA1 isoforms (Fig. 3.7 B).  
Taken together, no stabilization of L-OPA1 isoforms in the absence of Afg3l1, Afg3l2 
and paraplegin could be observed suggesting that the processing of OPA1 in mammals can 
occur independently of m-AAA proteases. Surprisingly, concomitant knockdown of Afg3l1 
and Afg3l2 resulted in drastically reduced levels of L-OPA1 isoforms accompanied by an 
accumulation of S-OPA1 isoforms. These results point to an increased processing or turnover 
of L-OPA1 isoforms in Afg3l1/Afg3l2-depleted MEFs.  
 
 
 
 
 
 
 
Figure 3.7 Loss of L-OPA1 isoforms in the absence of Afg3l1 and Afg3l2. 
(A) Immunoblot analysis of OPA1 isoforms in MEFs. 48 hrs after transfection of Spg7+/+ and Spg7-/--MEFs with 
siRNAs directed against Afg3l1 and Afg3l2, cells were lysed and subjected to SDS-PAGE followd by 
immunblot analysis. Specific anitsera recognizing OPA1, Afg3l1, Afg3l2 and 70 kDa subunit of Complex II 
(CII) were used. OPA1 isoforms are indicated and named L1, L2, S3, S4 and S5 according to Duvezin-Caubet 
et al., 2006. Afg3l1, L1; Afg3l2, L2. (B) Immunoblot analysis of OPA1 isoforms in HeLa cells. HeLa cells were 
transfected with siRNA specific for human AFG3L2 and Paraplegin. Immunoblot analysis was performed with 
α-OPA1 and α-CII. OPA1 isoforms were labeled as described in (A). Protein levels of Paraplegin and AFG3L2 
are shown in Fig. 3.6 C.  
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3.2.2.2 Downregulation of Afg3l1 and Afg3l2 results in mitochondrial 
fragmentation 
The dynamin-related GTPase OPA1 is essential for mitochondrial fusion (Olichon et al., 
2003; Cipolat et al., 2004; Chen and Butow). The presence of both, long and short OPA1 
isoforms was shown to be required for mitochondrial fusion activity (Song et al., 2007). 
Because knockdown of Afg3l1 and Afg3l2 resulted in loss of long OPA1 isoforms, it is 
conceivable that mitochondrial morphology is affected. Thus, mitochondria-targeted red 
fluorescent protein (mito-DsRed) was expressed in MEFs depleted of Afg3l1 and Afg3l2. 
Control cells displayed tubular mitochondrial morphology (Fig. 3.8 A). Furthermore, 
mitochondrial morphology was not drastically altered in Afg3l1- or Afg3l2-depleted MEFs 
when compared to control cells (Fig. 3.8 A and B). In contrast, more than 80% of the cells 
contained fragmented mitochondria after simultaneous knockdown of Afg3l1 and Afg3l2 
(Fig. 3.8 B). Thus, mitochondrial fragmentation in Afg3l1- and Afg3l2-depleted cells 
correlated with the loss of long OPA1 isoforms.  
 
 
 
 
 
Figure 3.8 Concomitant knockdown of Afg3l1 and Afg3l2 results in mitochondrial fragmentation. 
(A) Mitochondrial morphology after knockdown of Afg3l1 and Afg3l2. MEFs were transfected with siRNA 
against Afg3l1 and Afg3l2 followed by transfection with mito-DsRed. 48 hrs after transfection, cells were fixed 
with paraformaldehyde, nuclear DNA was stained with DAPI and mitochondrial morphology was analyzed by 
fluorescence microscopy. (B) Quantification of mitochondrial morphology. >150 cells were scored per 
experiment. Cells were classified into two classes containing either tubular or fragmented mitochondria. Bars 
represent means ± standard deviation (SD) of three independent experiments. C, control; L1, Afg3l1; L2, 
Afg3l2. 
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3.2.2.3 Expression of a non-cleavable long OPA1 isoform partially 
restores tubular morphology in Afg3l1/Afg3l2-depleted MEFs 
The balanced expression of long and short OPA1 isoforms was shown to be important 
for mitochondrial fusion activity (Song et al., 2007). This suggests that the mitochondrial 
fragmentation observed in Afg3l1/Afg3l2-depleted MEFs might be caused by the selective 
loss of long OPA1 isoforms. To substantiate this assumption, a Flag-tagged L-OPA1 isoform 
(OPA1-1ΔS1) lacking the processing site S1, was transiently transfected into MEFs followed 
by transfection of Afg3l1- and Afg3l2-siRNA (Fig. 3.9 A) (Ishihara et al., 2006). In parallel, 
a Flag-tagged S-OPA1 construct composed of the short form of variant 7 (amino acid 
230-970) fused to the mitochondrial targeting sequence of AIF (amino acids 1-95) was 
expressed (Fig. 3.9 A) (Ishihara et al., 2006). 
After 72 hrs, expression of the OPA1 constructs was monitored by immunoblot 
analysis. The expression of L-OPA1 variant 1ΔS1 was reduced after concomitant knockdown 
of Afg3l1 and Afg3l2 in MEFs (Fig. 3.9 B). Similarly, protein levels of S-OPA1 
(AIF-variant 7) were decreased. To visualize mitochondria morphology in transfected cells 
by fluorescence microscopy, OPA1 constructs were co-transfected with mito-DsRed in a 
DNA ratio of 4:1. No significant changes in mitochondrial morphology of control cells 
occurred upon exogenous expression of the OPA1 constructs (Fig. 3.9 C). Despite reduced 
expression levels of L-OPA1 variant 1ΔS1 in MEFs depleted of Afg3l1 and Afg3l2, the 
tubular mitochondria network was restored in ~40% of the cells (Fig. 3.9 B and C). In 
contrast, expression of S-OPA1 did not significantly affect mitochondrial morphology (Fig. 
3.9 C).  
In summary, L-OPA1 variant 1ΔS1 was shown to partially suppress mitochondrial 
morphology defects in the absence of Afg3l1 and Afg3l2. This strongly indicates that 
mitochondrial fragmentation can be attributed to the loss of long OPA1 isoforms.  
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Figure 3.9 Expression of L-OPA1 variant 1ΔS1 partially restores mitochondrial morphology in MEFs 
depleted of the m-AAA protease subunits Afg3l1 and Afg3l2. 
(A) Schematic representation of Flag-tagged OPA1 constructs. Variant 1ΔS1 (L-OPA1) represents rat splice 
variant 1 lacking processing site S1. AIF-variant 7 (S-OPA1) is composed of amino acids 230-997 of rat splice 
variant 7 fused to amino acids 1-95 of AIF (Ishihara et al., 2006). Both variants are Flag-tagged at the 
C-terminus. MTS, mitochondrial targeting sequence; TM, transmembrane domain; CC, coiled coil domains; 
GTPase, GTPase domain. (B) Expression of OPA1 variants in MEFs. Immunoblot analysis of MEFs after 
transfection with OPA1-1ΔS1 and S-OPA1 (AIF-variant 7) and siRNA against Afg3l1 and Afg3l2. Endogenous 
OPA1 isoforms and transfected Flag-tagged OPA1 variants were detected with α-OPA1 and α-Flag antibodies, 
respectively. As a loading control, α-CII (70 kDa subunit of Complex II) antibody was used. (C) Quantification 
of mitochondrial morphology in Afg3l2/Afg3l1-depleted MEFs after transfection with OPA1 constructs. MEFs 
were transfected with mito-DsRed and the indicated OPA1 constructs followed by transfection with Afg3l1- and 
Afg3l2-siRNA. After 48 hrs, mitochondrial morphology was analyzed by fluorescence microscopy and >150 
cells containing tubular or fragmented mitochondria were classified. Bars represent means ± SD of three 
independent experiments. L1, Afg3l1; L2, Afg3l2. 
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3.2.2.4 Mitochondrial respiration and membrane potential are maintained 
in m-AAA protease-depleted MEFs 
Mitochondrial dysfunction and dissipation of the mitochondrial membrane potential can 
induce conversion of long into short OPA1 isoforms accompanied by mitochondrial 
fragmentation (Duvezin-Caubet et al., 2006; Ishihara et al., 2006). Thus, an impaired 
respiratory activity of mitochondria might cause the altered OPA1 isoform pattern in m-AAA 
protease-depleted cells. Further evidence gives the observation that human HSP fibroblasts 
lacking paraplegin showed an impaired assembly of Complex I pointing to a reduced 
mitochondrial respiration (Atorino et al., 2003). 
Therefore, mitochondrial respiration was analyzed in Spg7+/+- and Spg7-/--MEFs after 
transfection with siRNA specific for Afg3l1 and Afg3l2. Endogenous respiration was not 
significantly affected under routine cell culture conditions (Fig. 3.10 A). However, when 
oligomycin-inhibited respiration was measured, a statistically significant increase of oxygen 
consumption upon downregulation of Afg3l1 and Afg3l2 was observed. This increase in 
respiration compared to wt cells indicates a proton leak across the inner membrane of 
Afg3l1/Afg3l2-depleted mitochondria. Furthermore, maximum respiratory capacity, 
mimicked by CCCP-induced uncoupled respiration, was decreased. The ratio of CCCP-
induced respiration to oligomycin-inhibited respiration determines the respiratory control ratio 
(RCR), an indicator for the coupling efficiency between respiration and phosphorylation. 
Knockdown of Afg3l1 and Afg3l2 in Spg7+/+- and Spg7-/--MEFs led a two-fold decrease in 
RCR. Respiratory defects due to differences in the mitochondrial content of the cells were 
excluded using citric synthase activity as a control (personal communication, A. Bernacchia). 
Taken together, concomitant depletion of the m-AAA protease subunits Afg3l1 and Afg3l2 
resulted in a slight impairment of mitochondrial respiratory functions which most likely is 
caused by a partial uncoupling of oxidative phosphorylation. Nevertheless, under routine cell 
culture conditions, when ATP demand and turnover are low, endogenous respiration was not 
affected. 
To analyze the mitochondria membrane potential in living cells, MEFs were stained with 
the lipohilic fluorescent dye JC-1 and analyzed by FACS. JC-1 is a cationic dye that 
visualizes mitochondrial polarization by shifting its fluorescence emission form from green 
(~525 nm) to red (~590 nm) due to a Δψ-dependent uptake of red-fluorescent J-aggregates 
into mitochondria (Smiley et al., 1991; Reers et al., 1995). The mean of three independent 
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experiments revealed no significant differences in the intensity of red JC-1 fluorescence upon 
downregulation of any m-AAA protease subunit (Fig 3.10 B).  
 
 
 
 
 
 
Figure 3.10 Analysis of mitochondrial respiratory functions in MEFs upon knockdown of m-AAA 
protease subunits. 
(A) Measurement of oxygen consumption in intact cells. Spg7+/+- Spg7-/--MEFs were transfected with siRNA 
against Afg3l1 and Afg3l2. Respiration was measured under routine conditions, after the addition of 2 µM 
oligomycin and during titrations with 250-750 nM of CCCP. Respiratory control ratio (RCR) was determined 
from the ratio of CCCP-induced to oligomycin-inhibited respiration. Bars represent means ± standard deviation 
(SD) of three independent experiments. **, p<0.01; ***, p<0.001. (B) Maintenance of membrane potential upon 
downregulation of m-AAA protease subunits. MEFs transfected with the indicated siRNAs were stained with the 
fluorescent dye JC-1 and fluorescence at 590 nm was measured by FACS. The relative fluorescence intensity 
compared to wt is indicated. CCCP-treated cells were used as a negative control. Data represent mean ± SD of 
three independent experiments. C, control. (C) Analysis of ROS production. Two days after transfection with 
siRNAs against Afg3l1 and Afg3l2, ROS production in intact cells was measured using carboxy-H2DFCDA 
followed by FACS analysis. To induce endogenous ROS production, control cells were pretreated with 10 µM or 
20 µM antimycin A (AA). Para, paraplegin; L1, Afg3l1; L2, Afg3l2. 
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The mitochondrial respiratory chain has been shown to be one of the major cellular 
producers of reactive oxygen species (ROS) due to electron leakage (Loschen and Azzi, 1974; 
Boveris and Cadenas, 1975). To analyze whether knockdown of Afg3l1 and Afg3l2 and the 
observed mitochondrial fragmentation are linked to increased ROS production, ROS levels in 
MEFs were measured using the oxidation-sensitive fluorescence dye carboxy-H2DFCDA. 
Pretreatment of cells with 10 µM or 20 µM antimycin A resulted in a drastic increase of 
H2DFCDA fluorescence because of induced ROS production by inhibition of Complex III 
(Fig. 3.10 C). However, depletion of Afg3l1 an Afg3l2 did not enhance intracellular ROS 
production. 
In conclusion, these results indicate that the loss of long OPA1 isoforms in the absence of 
the m-AAA protease is not caused by an impaired mitochondrial respiration or membrane 
potential. Furthermore, contrary to published results, no statistically significant respiratory 
deficiencies could be detected in paraplegin-deficient MEFs (Atorino et al., 2003).  
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3.2.3 Analysis of OPA1 processing in the absence of Afg3l and Afg3l2 
 
3.2.3.1 Induced cleavage at processing site S1 and destabilization of 
long OPA1 isoforms in the absence of Afg3l1 and Afg3l2 
Human OPA1 is encoded by eight different splice variants resulting from alternative 
splicing of exons 4, 4b and 5b (Delettre et al., 2001). All OPA1 mRNA splice forms encode a 
processing site S1 in exon 5 in addition to the MPP cleavage site (Fig. 3.11 A). A second 
processing site S2 is encoded by exon 5b which is only present in splice variants 4, 6, 7 and 8 
(Ishihara et al., 2006; Olichon et al., 2006; Song et al., 2007). To further dissect the 
regulatory functions of m-AAA proteases for the processing of OPA1, we analyzed the 
consequences of m-AAA protease downregulation on individual splice variants. Therefore, 
Flag-tagged variant 1 harbouring cleavage site 1 and variant 7, which contains both cleavage 
sites were transiently expressed in MEFs followed by knockdown of Afg3l1 and Afg3l2. 
The first focus was on the role of m-AAA proteases in processing at site S1 using 
expression of Flag-tagged OPA1 variant 1. In control cells, variant 1 produced a single 
L-OPA1 isoform and a less abundant S-OPA1 isoform resulting from S1-cleavage (Fig. 3.11 
B). They were shown to correspond to OPA1 isoforms L2 and S5 of endogenous OPA1 
(Duvezin-Caubet et al., 2007) (Fig.3.7 A). Strikingly, depletion of Afg3l1 and Afg3l2 caused 
the complete loss of L-OPA1 accompanied by an accumulation of S-OPA1 pointing to 
accelerated cleavage at processing site S1 (Fig. 3.11 B). To investigate whether L-OPA1 is 
not only processed more efficiently but also faster degraded, cells were transfected with an 
L-OPA1 variant in which processing site S1 was deleted (OPA1-1ΔS1) (Fig. 3.9 A) (Ishihara 
et al., 2006). Expression of OPA1-1ΔS1 in control cells resulted exclusively in the formation 
of L-OPA1 (Fig. 3.11 B). Remarkably, 72 hrs after transfection L-OPA1 could not be 
detected anymore in cells depleted of Afg3l1 and Afg3l2 (Fig. 3.11 B). To distinguish 
between impaired synthesis and increased degradation of OPA1-1ΔS1, the cytosolic protein 
synthesis was inhibited for 6 hrs using cycloheximide. In contrast to control cells in which 
L-OPA1 level remained stable after inhibition of protein synthesis, the protein level was 
drastically reduced in MEFs transfected with Afg3l1 and Afg3l2 siRNA (Fig. 3.11 C). This 
indicates that in the absence of Afg3l1 and Afg3l2 not only S1-cleavage but also turnover of 
L-OPA1 isoforms is increased.  
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Figure 3.11 Depletion of Afg3l1 and Afg3l2 results in increased cleavage at processing site S1 and 
destabilization of L-OPA1 isoforms.  
(A) Schematic representation of OPA1 splice variant 1 and splice variant 7. Splice variant 1 (OPA1-1) and splice 
variant 7 (OPA1-7) differ in the presence of exon 5b. Cleavage of the mitochondrial targeting signal (MTS) by 
the mitochondrial processing peptidase (MPP) produces the long isoforms. Additional cleavage at processing 
sites S1 or S2 leads to the short isoforms. TM, transmembrane domain; CC, coiled-coil region. (B) Effects of 
Afg3l1 and Afg3l2 siRNA on OPA1 splice variants 1 and 1ΔS1. MEFs were transfected with Flag-tagged OPA1 
variants followed by siRNA transfection. 72 hrs after the first transfection cells were harvested. Cell lysates were 
analyzed by SDS-PAGE and immunoblotting with α-Flag and α-CII antibodies. Expression of variant 1 
produces a long (L) and a short (S) OPA1 isoform. Upon deletion of processing site 1 (1ΔS1), only the L-OPA1 
isoform is expressed. (C) Cycloheximide-chase of OPA1-1ΔS1 upon knockdown of Afg3l1 and Afg3l2. MEFs 
were transfected with OPA1 variant 1ΔS1 and siRNA directed against Afg3l1 and Afg3l2. Two days after 
transfection, cells were incubated for 6 hrs with 100 µg/ml cycloheximide (CHX) and analyzed as described in 
(B). (D) and (E) Expression of OPA1 splice variant 1 (D) and 1ΔS1 (E) in paraplegin-deficient MEFs. Spg7+/+- 
and Spg7-/--MEFs were transfected with Flag-tagged OPA1 variants followed by transfection of Afg3l1 and 
Afg3l2 siRNA. Cell lysates were analyzed as described in (B) with antibodies recognizing the Flag-tag, OPA1 
and CII (70 kDa subunit of Complex II). L1, Afg3l1; L2, Afg3l2. 
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Interestingly, the third subunit of the m-AAA protease, paraplegin, has been observed to 
stimulate cleavage at S1 when overexpressed (Ishihara et al., 2006). This suggests that 
paraplegin might be involved in the accelerated processing caused by the absence of Afg3l1 
and Afg3l2. Therefore, Afg3l1 and Afg3l2 were downregulated in Spg7-/--cells after 
transfection with OPA1 variant 1. The absence of paraplegin did not alter the balance of long 
and short isoforms compared to wt (Fig. 3.11 D). Furthermore, increased processing of 
variant 1 induced by knockdown of Afg3l1 and Afg3l2 could be observed to similar extents in 
Spg7+/+-and Spg7-/--MEFs (Fig. 3.11 D). To assign whether the degradation of L-OPA1 is 
mediated by paraplegin, OPA1 variant-1ΔS1 was expressed in paraplegin-deficient cells. 
However, loss of L-OPA1 was also observed in the absence of paraplegin (Fig. 3.11 E). 
 
 
 
 
 
 
 
 
Figure 3.12 The m-AAA protease does not affect cleavage at processing site S2. 
(A) Effect of Afg3l1 and Afg3l2 knockdown on S2-cleavage of OPA1 splice variant 7. MEFs were transfected 
with Flag-tagged rat OPA1 variant 7 (OPA1-7) followed by siRNA transfection to downregulate either Afg3l1 
and Afg3l2 or Yme1l1. Expression of OPA1 variant 7 was analyzed by immunoblotting using α-Flag antibodies. 
Downregulation of Yme1l1 was confirmed with α-Yme1l1 immunoblotting. (B) Effects of Afg3l1 and Afg3l2 
knockdown on S2-cleavage of OPA1 splice variant 7ΔS1. Flag-tagged OPA1 variant 7 and variant 7ΔS1 were 
expressed in MEFs and expression was detected by immunoblotting with α-Flag antibody. The resulting OPA1 
isoforms are labeled according to Fig. 3.7 A. OPA1 isoform S3 is produced by processing of L-OPA1 at 
cleavage site S1 whereas isoform S4 is the product of processing at cleavage site S2. The asterisk indicates a 
novel cleavage product for 7ΔS1. CII, 70 kDa subunit of Complex II. L1, Afg3l1; L2, Afg3l2. 
 
 
 
Given the enhanced cleavage at site S1 in the absence of Afg3l1 and Afg3l2, possible 
effects on processing at site S2 were examined. Notably, the i-AAA protease Yme1l1 was 
found to be important for cleavage at processing site S2 (Song et al., 2007). As result of 
cleavage at processing sites S1 and S2, expression of OPA1 variant 7 in MEFs produced two 
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short OPA1 isoforms, presumably S3 and S4 (Fig. 3.12 A). Knockdown of Afg3l1 and Afg3l2 
led to the accumulation of isoform S3 whereas S4 seemed not to be affected. In agreement 
with previous findings, the knockdown of Yme1l1 abolished S2-cleavage resulting in 
drastically reduced levels of isoform 4 (Fig. 3.12 A) (Song et al., 2007). To substantiate that 
S2-cleavage occurs independently of Afg3l1 and Afg3l2, OPA1 variant 7ΔS1, lacking the 
processing site S1 was expressed (Ishihara et al., 2006). Consistently, downregulation of 
Afg3l1 and Afg3l2 led to the loss of L-OPA1 without any impact on the short isoform S4 
produced by S2-cleavage (Fig. 3.12 B). In addition, there is a slight accumulation of a novel 
cleavage product (Fig. 3.12 B). 
In summary, these results indicate that downregulation of the m-AAA protease subunits 
Afg3l1 and Afg3l2 enhances OPA1 processing at cleavage site S1 but not at S2. Furthermore, 
the degradation of long OPA1 isoforms is accelerated which indicates a decreased stability in 
the absence of functional m-AAA protease complexes.  
 
 
 
3.2.3.2 Functions of other mitochondrial proteases in OPA1 processing  
Since mammalian m-AAA proteases seem to be dispensable for OPA1 processing, the 
involvement of other mitochondrial proteases was investigated. Of special interest was the 
identification of proteases responsible for the accelerated processing of L-OPA1 isoforms at 
processing site S1 in the absence of Afg3l1 and Afg3l2.  
The i-AAA protease Yme1l1 has already been implicated in the proteolytic processing at 
site 2 (Song et al., 2007). Therefore, MEFs were transfected with two different siRNAs 
against Yme1l1 which resulted in the efficient reduction of Yme1l1 protein level (Fig. 
3.13 A). In agreement with published observations, immunoblot analysis using α-OPA1 
antibody revealed a reduced protein level of OPA1 isoform S4, the cleavage product of 
processing at site S2 (Fig. 3.13 A) (Song et al., 2007). However, induced processing of OPA1 
after downregulation of Afg3l1 and Afg3l2 occured also in the absence of Yme1l1 (Fig. 3.13 
A).  
The mitochondrial protease Lon resides in the matrix and has been implicated in the 
quality control of proteins (Suzuki et al., 1994; Van Dyck et al., 1994; Bota and Davies, 
2002). Therefore, the requirement of Lon for the degradation of L-OPA1 isoforms was 
examined. Although efficient downregulation of Lon was achieved, L-OPA1 isoforms were 
not stabilized in Afg3l1/Afg3l2-depleted MEFs (Fig. 3.13 B). Other likely candidates for 
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OPA1 processing are PARL (presenilin-associated, rhomboid like protease) residing in the 
inner mitochondrial membrane and the oligomeric serine protease HtrA2/Omi which is 
localized to the inter membrane space (Pellegrini et al., 2001; Suzuki et al., 2001; Hegde 
et al., 2002). However, MEFs derived from Parl-/-- and HtrA2-/- mice did not show an effect 
on the OPA1 isoform pattern or on the induced proteolysis of long isoforms upon knockdown 
of Afg3l1 and Afg3l2 (Fig. 3.13 C and D) (Martins et al., 2004; Cipolat et al., 2006). 
 
 
 
 
 
 
 
Figure 3.13 The mitochondrial proteases Yme1l1, Lon, Parl and HtrA2 are dispensable for the induced 
proteolysis of L-OPA1. 
(A) MEFs were transfected with specific siRNAs against Yme1l1 or Lon alone or together with Afg3l1 and 
Afg3l2 siRNA. Downregulation of Yme1l1 and Lon was confirmed by immunoblotting using antibodies specific 
for Yme1l1 and Lon, respectively. (B) Parl-/--MEFs and HtrA2-/--MEFs and their corresponding wt controls were 
transfected with control siRNA or siRNA against Afg3l1 and Afg3l2. OPA1 isoform pattern was investigated by 
SDS-PAGE and immunoblotting with α-OPA1 and α-CII (70 kDa subunit of Complex II) antibodies. An 
unspecific crossreaction of α-Lon antibody is marked with an asterisk. L1, Afg3l1; L2, Afg3l2. 
 
 
To further investigate the function of Parl, HtrA2 and Yme1l1 in the inducible 
processing of OPA1 at cleavage site S1, Flag-tagged OPA1 isoform 1 was expressed in MEFs 
transfected with Yme1l1 was well as in Parl-/-- and HtrA2-/--MEFs (Fig. 3.14 A and B). 
Immunoblotting using an α-Flag antibody revealed that in the absence of these proteases, 
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downregulation of Afg3l1 and Afg3l2 still led to accelerated conversion of L-OPA1 to S-
OPA1 isoforms (Fig. 3.14 A and B).  
Taken together, these results revealed that the mitochondrial proteases Parl, HtrA2, 
Lon and Yme1l1 are dispensable for the induced proteolysis of L-OPA1 isoforms upon 
knockdown of Afg3l1 and Afg3l2. Furthermore, Yme1l1, HtrA2 and Parl are not required for 
constitutive cleavage of L-OPA1 isoforms whereas Yme1l1 is involved in the generation of 
isoform S4, as previously published (Griparic et al., 2007; Song et al., 2007). 
 
 
 
 
 
 
Figure 3.14 The mitochondrial proteases Yme1l1, Parl and HtrA2 are dispensable for induced processing 
at site S1. 
 (A) MEFs were transfected with Flag-tagged OPA1 variant 1 followed by transfection of specific siRNA against 
Yme1l1 alone and together with Afg3l1 and Afg3l2 siRNA. Downregulation of Yme1l1 was confirmed by 
immunoblotting using a-Yme1l1. (B) Parl-/--MEFs and HtrA2-/--MEFs and their corresponding wt controls were 
transfected with Flag-tagged OPA1 variant 1 and siRNAs against Afg3l1 and Afg3l2. Analysis was performed 
by SDS-PAGE and immunoblotting with α-OPA1 and α-Flag antibodies. As loading controls the antibodies 
α-CII (70 kDa subunit Complex II) and α-Aconitase (Aconitase 2) were used. L, L-OPA1 isoform; S, S-OPA1 
isoform. L1, Afg3l1; L2, Afg3l2. 
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3.2.3.3 Analysis of OPA1 processing in the presence of different 
protease inhibitors 
Similar to m-AAA protease depletion, loss of mitochondrial membrane potential by 
CCCP has been shown to enhance the cleavage of OPA1 (Duvezin-Caubet et al., 2006; 
Ishihara et al., 2006; Song et al., 2007). Furthermore, CCCP-induced OPA1 processing was 
delayed in the presence of o-phenantroline, a membrane-permeable bivalent metal chelator 
known to inhibit metalloproteases (Duvezin-Caubet et al., 2006; Ishihara et al., 2006; 
Guillery et al., 2008). Therefore, OPA1 processing was investigated after knockdown of 
Afg3l1 and Afg3l2 in the presence of o-phenantroline and other membrane-permeable 
protease inhibitors. Flag-tagged variant 1 was expressed in MEFs followed by transfection 
with Afg3l1 and Afg3l2 siRNA. To inhibit the four major groups of proteases, 
serineproteases, cysteineproteases, aspartylproteases and metalloproteases, cells were 
incubated with the respective inhibitors Pefabloc, E-64, Pepstatin A and o-phenantroline. 
Since recent reports suggest a role of the proteasome in mitochondrial protein quality control, 
the proteasome inhibitor MG132 was included in this study (Margineantu et al., 2007; Radke 
et al., 2008). As previously observed, downregulation of Afg3l1 and Afg3l2 resulted in the 
accumulation of the short isoform of variant 1 (Fig. 3.15 A). Incubation with any of the 
protease inhibitors did not impair the accelerated conversion of L-OPA1 to S-OPA1 (Fig. 3.15 
A, left panel). However, positive controls for the inhibitory effect on proteases are missing. 
Strikingly, L-OPA1 and the putative precursor of OPA1 were stabilized in the presence of o-
phenantroline and MG132 in Afg3l1/ Afg3l2-depleted MEFs (Fig 3.15 A, left panel). Similar 
accumulations of long OPA1 isoforms in the presence of these protease inhibitors were 
observed in control cells (Fig 3.15 A, right panel). From these experiments, it is unclear 
whether the accumulation of L-OPA1 and its putative precursor is due to an impaired 
processing of the L-OPA1 isoform or a stabilisation of newly synthesized OPA1 precursors.  
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Figure 3.15 Stabilisation of newly synthesized OPA1 using the protease inhibitors MG132 and 
1,10-phentantroline.  
(A) Processing of OPA1 variant 1 in the presence of different protease inhibitors. MEFs were transfected with 
Flag-tagged OPA1 variant 1 together with Afg3l1 and Afg3l2 siRNA. After 48 hrs, MEFs were incubated for 
5 hrs with 10 µM Pepstatin A, 50 µM E-64, 0.5 mM Pefabloc, 0.5 mM o-phenantroline (o-phe) or 5 µM MG132 
and subsequently subjected to SDS-PAGE and immunoblotting. Expression of OPA1 variant 1 and endogenous 
OPA1 was analyzed using α-Flag and α-OPA1 antibodies, respectively, and as a control antibody against 
subunit 2 of Complex II (CII). (B) CHX-sensitive stabilization of OPA1 variant 1ΔS1 by o-phenantroline and 
MG132. MEFs were transfected with Flag-tagged OPA1 variant 1ΔS1 followed by siRNA transfection with 
Afg3l1 and Afg3l2. 72 hrs after transfection, 0.5 mM o-phenantroline and 5 µM MG132 were added and 
followed by addition of 100 µg/ml cyclohexmide after 30 min and further incubation for 4.5 hrs. MEFs were 
analyzed as described in (A). p, precursor; L, L-OPA1; S3, short OPA1 isoform 3. L1, Afg3l1; L2, Afg3l2. 
 
 
 
To examine whether the inhibition of proteases with MG132 and o-phenantroline 
stabilizes only newly synthesized OPA1, cells were incubated in the presence of 
cycloheximide (CHX) to inhibit protein synthesis. Before, MEFs were transfected with Flag-
tagged OPA1-1ΔS1 and siRNA against Afg3l1 and Afg3l2. As previously shown, an 
accelerated degradation of OPA1-1ΔS1 in the presence of CHX was observed in 
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Afg3l1/Afg3l2-depleted MEFs but not in control cells (Fig. 3.11 E and 3.15 B). After 
incubation with the inhibitors MG132 and o-phenantroline, L-OPA1 and its precursor were 
stabilized in MEFs (Fig. 3.15 B). However, if cytosolic protein synthesis was blocked 30 min 
after addition of the protease inhibitors, long OPA1 isoforms of endogenous OPA1 and 
transfected OPA1-1ΔS1 were degraded to similar extents as without protease inhibitors (Fig. 
3.15 B). This indicates, that accumulation of long OPA1 isoforms after protease inhibition 
with MG132 and o-phenantroline results from stabilization of newly synthesized OPA1 
precursor protein and not from an impaired processing of L-OPA1 isoforms. In line with 
previous publications, the proteasome inhibitor MG132 most likely stabilizes mitochondrial 
precursor protein in the cytosol resulting in increased mitochondrial import (Margineantu et 
al., 2007; Radke et al., 2008). The accumulation of OPA1 precursor by o-phenantroline might 
result from inhibition of the mitochondrial processing peptidase (MPP), a metalloprotease 
responsible for the removal of mitochondrial targeting sequences. However, it should be 
emphasized that from these results a metalloprotease-dependent cleavage at processing site S1 
cannot be excluded. Consistently, accelerated cleavage of long OPA1 isoforms in isolated 
mitochondria can be inhibited in the presence of o-phenantroline (Ishihara et al., 2006; 
Guillery et al., 2008). 
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3.2.4 Mitochondrial hyperfusion in m-AAA protease- and 
prohibitin-depleted MEFs 
 
3.2.4.1 CHX-induced hyperfusion is dependent on the m-AAA protease 
but not on prohibitins 
Recently, it has been observed that mitochondria undergo extensive fusion events 
and form a highly interconnected network in MEFs exposed to low concentrations of 
diverse stress stimuli (D. Tondera and J.-C. Martinou, personal communication). 
Interestingly, this mitochondrial hyperfusion was shown to be dependent on a balanced 
expression of long and short OPA1 isoforms. Therefore, the dependence of mitochondrial 
hyperfusion on the m-AAA protease was investigated. Interestingly, depletion of 
prohibitin 2 has been recently demonstrated to affect the OPA1 isoform pattern and 
mitochondrial morphology in a manner similar to the m-AAA protease (Merkwirth et al., 
2008). The m-AAA protease and prohibitins, both residing in the inner mitochondrial 
membrane, were shown to interact and form a supercomplex (Metodiev, 2005). Thus, 
functional analysis of prohibitins in mitochondrial hyperfusion was included in addition 
to the analysis of m-AAA proteases.  
Knockdown of either Afg3l1 and Afg3l2 or prohibitin 2 (Phb2) resulted in 
decreased levels of L-OPA1 isoforms and an accumulation of S-OPA1 isoforms (Fig. 
3.16 A). This was accompanied by mitochondrial fragmentation (Fig. 3.16 B). To induce 
mitochondrial tubulation, MEFs were incubated in the presence of cycloheximide 
(CHX). Already after 3 hrs, tubular mitochondria were converted into a highly 
interconnected network in ~90% of control cells (Fig. 3.16 B and C). Strikingly, 
mitochondrial tubulation in the presence of CHX was completely abolished in Afg3l1- 
and Afg3l2-depleted MEFs and mitochondria stayed fragmented (Fig. 3.16 B and C). 
This is in contrast to fragmented mitochondria depleted of Phb2 which were observed to 
hyperfuse in ~80% of the cells (Fig. 3.16 B and C).  
In conclusion, the absence of m-AAA proteases and prohibitins affects the loss of 
long OPA1 isoforms similarly whichr leads to mitochondrial fragmentation. In m-AAA 
protease-deficient MEFs mitochondrial hyperfusion was completely abolished. However, 
fragmented mitochondria formed highly interconnected networks in prohibitin-depleted 
MEFs indicating fusion activity despite an apparently impaired OPA1 function. 
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Figure 3.16 CHX-induced mitochondrial hyperfusion is dependent on the m-AAA protease but not on 
prohibitins. 
(A) Immunoblot analysis of MEFs transfected with siRNA against Afg3l1 and Afg3l2 or Phb2. MEFs were 
transfected with siRNA against Afg3l1 and Afg3l2 or Phb2 followed by transfection with mito-DsRed. 48 hrs 
after transfection, cells were lysed and subjected to SDS-PAGE and immunoblotting. To assess the knockdown 
efficiency antisera recognizing Afg3l1, Afg3l2, Phb2, and as controls, Slp2 (stomatin-like protein 2) and CII 
(70 kDa subunit of Complex II) were used. In addition, the OPA1 isoform pattern was analyzed by 
immunodecoration with the antibodies α-OPA1 and, as a loading control, α-CII. (B) CHX-induced 
mitochondrial morphology. MEFs were transfected with siRNA against Afg3l1 and Afg3l2 or Phb2 followed by 
transfection with mito-DsRed. 48 hrs after transfection, the cells were incubated in the presence of 
cycloheximide (CHX) for 3 hrs and mitochondrial morphology was analyzed by fluorescence microscopy. (C) 
Quantification of mitochondrial morphology after CHX-induced hyperfusion. MEFs transfected with siRNA 
were incubated with CHX for 3 and 6 hrs. More than 150 cells were scored for each experiment. Cells were 
classified into three classes containing hyperfused, tubular or fragmented mitochondria. Bars represent means ± 
SD of three independent experiments. L1, Afg3l1; L2, Afg3l2. 
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3.2.4.2 Knockdown of Phb2 in OPA1- and m-AAA protease-depleted 
MEFs does not restore mitochondrial hyperfusion  
 
In contrast to fragmented mitochondria in Afg3l1/Afg3l2-depleted MEFs, prohibitin-
depleted fragmented mitochondria were shown to fuse in the presence of cycloheximide 
despite an altered OPA1 pattern. In both cases, mitochondrial fragmentation under steady 
state levels is ascribed to an imbalance of short and long OPA1-isoforms (Merkwirth et al., 
2008). Similarly to m-AAA protease depletion, it was shown that the loss of OPA1 results in 
mitochondrial fragmentation and a block in hyperfusion (D. Tondera and J.-C. Martinou, 
personal communication; Griparic et al., 2004; Olichon et al., 2003). Prohibitin-depleted 
mitochondria are fragmented under normal conditions due to an impaired function of OPA1 
(Merkwirth et al., 2008). Since OPA1 is implicated in the fusion of mitochondrial inner 
membranes, it is striking that prohibitin-depleted mitochondria are able to fuse under certain 
conditions unlike mitochondria depleted of OPA1 or the m-AAA protease. These observations 
led to the hypothesis, that the absence of prohibitins might suppress the dependence of 
mitochondrial fusion on OPA1 upon induction with CHX.  
To investigate whether the knockdown of Phb2 restores the tubulation ability in 
fragmented mitochondria of m-AAA protease-depleted or OPA1-depleted MEFs, these 
proteins were simultaneously downregulated and mitochondrial morphology was analyzed. 
Efficient downregulation of either Phb2 or Afg3l1 and Afg3l2 resulted in the loss of L-OPA1 
isoforms. Similar observations were made upon simultaneous knockdown of Afg3l1 and 
Afg3l2 together with Phb2 (Fig.3.17 A). Furthermore, OPA1 was efficiently depleted using 
siRNA-mediated downregulation (Fig.3.17 A). Under routine cell culture conditions, 80-90% 
MEFs depleted of either OPA1 or Afg3l1 and Afg3l2 contained fragmented mitochondria 
(Fig. 3.17 B). Similarly, fragmented mitochondria were observed in ~70 % of prohibitin-
depleted cells. After incubation with CHX, mitochondria stayed fragmented in the absence of 
either OPA1 or Afg3l1 and Afg3l2 in contrast to prohibitin-depleted mitochondria which 
formed a highly elongated mitochondrial network in ~70% of the cells. However, the absence 
of Phb2 in either Afg3l1- and Afg3l2-depleted or OPA1-depleted MEFs did not restore the 
ability of fragmented mitochondria to tubulate under hyperfusion conditions. The requirement 
of active OPA1 in these cells for hyperfusion is not suppressed in the absence of prohibitins. 
Therefore, OPA1 and the m-AAA protease seem to be essential for mitochondrial 
hyperfusion. 
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Figure 3.17 Knockdown of Phb2 does not restore CHX-induced mitochondrial hyperfusion in MEFs 
depleted of either OPA1 or Afg3l1 and Afg3l2 
(A) Immunoblot analysis of MEFs transfected with siRNA against Afg3l1, Afg3l2, Phb2 and OPA1. MEFs were 
transfected with indicated siRNAs followed by transfection with mito-DsRed. Cells were lysed after incubation 
with cycloheximide (CHX) for 3 hrs and subjected to SDS-PAGE and immunoblotting. To assess consequences 
on OPA1 isoform pattern and knockdown efficency of Phb2, antisera recognizing OPA1 and Phb2 and, as 
loading controls, 70 kDa subunit of Complex II (CII) and subunit 2 of CIII (CIII) were used. (B) Quantification 
of mitochondrial morphology after CHX-induced hyperfusion in the absence of Phb2. MEFs transfected with 
indicated siRNAs and mito-DsRed were incubated with CHX for 3 hrs. More than 150 cells were scored for each 
experiment. Cells were classified into three classes containing hyperfused, tubular or fragmented mitochondria. 
L1, Afg3l1; L2, Afg3l2. 
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4 Discussion 
 
4.1 Tissue-specific consequences of paraplegin deficiency on 
 mitochondrial protein synthesis 
 
Mutations in the mammalian m-AAA protease subunit paraplegin are associated with 
axonal degeneration in the neurodegenerative disease HSP. Studies in the yeast S. cervisiae 
revealed crucial functions of the m-AAA protease for mitochondrial biogenesis (Koppen and 
Langer, 2007; Tatsuta and Langer, 2008). In particular, the recent identification of the 
mitochondrial ribosomal subunit MrpL32 as substrate of the yeast m-AAA protease suggested 
an impaired mitochondrial translation as the molecular defect causative for the axonal 
degeneration upon loss of paraplegin (Nolden et al., 2005; Rugarli and Langer, 2006). 
MrpL32 is cleaved by the m-AAA protease to its mature form which is essential for 
mitochondrial protein synthesis in yeast. The high sequence conservation of m-AAA 
proteases and MrpL32 from yeast to mammals and successful complementation studies 
suggest a functional conservation of the m-AAA protease-dependent proteolytic activation of 
MrpL32 (Atorino et al., 2003; Nolden et al., 2005). In this study, we used mitochondria 
isolated from paraplegin-deficient mice to further clarify the function of paraplegin in the 
regulation of Mrpl32 activity and its implication in the pathogenesis of HSP.  
Reduced amounts of mature Mrpl32 were present in liver mitochondria lacking 
paraplegin consistent with an impaired proteolytic maturation. The mRNA level and protein 
stability of Mrpl32 were not affected in the absence of paraplegin suggesting that they are not 
the cause for reduced levels of mature Mrpl32. Import of Mrpl32 precursor protein into 
mitochondria lacking paraplegin revealed no defect in the maturation of Mrpl32. Since these 
import experiments were done with isolated mitochondria, in conditions far from in vivo ones, 
the presence of a slight impairment in the proteolytic maturation of Mrpl32 in vivo cannot be 
completely ruled out. Consistently, direct evidence for the ability of mammalian m-AAA 
proteases to process murine Mrpl32 were obtained by reconstitution experiments in yeast 
(Nolden et al., 2005). Nevertheless, the analysis of paraplegin-deficient mice clearly 
demonstrate that Mrpl32 can be cleaved in the absence of paraplegin. Most likely as a 
consequence of a decreased Mrpl32 steady state level, protein synthesis rates were reduced to 
50% in liver mitochondria lacking paraplegin compared to wt. Notably, mitochondrial 
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translation was not affected in brain and spinal cord isolated from paraplegin-deficient mice. 
Because essential components of the respiratory chain complexes are mitochondrially 
encoded, the reduced mitochondrial protein synthesis in liver should result in a respiratory 
deficiency. Conversely, no decrease in the respiration of paraplegin-deficient liver 
mitochondria was observed compared to wt. Since mitochondrial protein synthesis was not 
completely abolished, the residual translation activity may be sufficient to maintain 
respiratory activity. This implies that mitochondrially encoded respiratory chain subunits are 
synthesized in excess in wt liver mitochondria and can be used as a reserve to compensate for 
a respiratory deficit (Rossignol et al., 2003).  
The mild effects on Mrpl32 and mitochondrial translation in mitochondria lacking 
paraplegin point to proteases with redundant functions. Since additional m-AAA protease 
subunits are present in human and mice, they represent likely candidates to substitute for the 
loss of paraplegin. Indeed, evidence for the assembly of the murine m-AAA protease subunits 
Afg3l1 and Afg3l2 into proteolytically active homo- and hetero-oligomeric complexes in liver 
and brain mitochondria of paraplegin-deficient mice was obtained (Koppen et al., 2007). 
Similarly, the ability of the human m-AAA protease subunit AFG3L2 to build up 
proteolytically active complexes in human HSP fibroblasts lacking paraplegin was proposed 
(Koppen et al., 2007). Therefore, a lack of paraplegin does not result in a complete loss of 
m-AAA protease activity but might rather lead to a reduction of the amount of m-AAA 
protease complexes and differences in their subunit composition.  
The liver-specific impairment of mitochondrial protein synthesis in the absence of 
paraplegin might be explained by a lower threshold level towards an impaired maturation of 
Mrpl32 in liver compared to brain and spinal cord (Rossignol et al., 2003). Alternatively, the 
tissue-specific difference can be rationalized by a differential expression of the m-AAA 
protease subunits Afg3l1 and Afg3l2 in liver, brain and spinal cord. Indeed, Afg3l2 was found 
to be 10-fold more abundant in brain than in liver mitochondria compared to Afg3l1 (Koppen 
et al., 2007). Remarkably, the relative abundance of Afg3l1 and Afg3l2 is not altered in the 
absence of paraplegin (Koppen et al., 2007). Thus, m-AAA-protease complexes containing 
either Afg3l2 or also Afg3l1 might complement for the lack of paraplegin in brain to a higher 
extent than in liver. Conversely, the low abundance of Afg3l2 in liver might not be sufficient 
to substitute for the housekeeping functions of paraplegin-containing m-AAA proteases and 
results in reduced mitochondrial protein synthesis. A similar explanation has been proposed 
for tissue-specific defects due to mutations in the mitochondrial translation factor EGF1 
(Antonicka et al., 2006). Here, a varying abundance of several mitochondrial translation 
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factors in different tissues was proposed to determine the variable effects on translation 
efficiency. Because brain and spinal cord are mostly affected in HSP, a defect in 
mitochondrial translation might not be the main molecular mechanism resulting in the 
neurodegeneration due to a loss of paraplegin. Nevertheless, it should be noted that only a 
subset of mitochondria was observed to be affected in neurons of paraplegin-deficient mice 
(Ferreirinha et al., 2004). Thus, the possibility of a mitochondrial translation defect confined 
to this mitochondrial subpopulation cannot be ruled out. 
In conclusion, paraplegin-deficient mice exhibit a liver-specific mitochondrial 
translation defect associated with reduced Mrpl32 levels which points to conserved functions 
of m-AAA proteases from yeast to mammals. While affected in liver, mitochondrial protein 
synthesis proceeds normally in brain and spinal cord mitochondria of paraplegin-deficient 
mice suggesting that an impaired mitochondrial protein synthesis does not seem to be the 
primary molecular defect causative for the axonal degeneration. 
 
 
 
 
4.2 Axonal degeneration in paraplegin-deficient mice occurs in 
 the absence of a general mitochondrial respiration defect 
 
Many neurodegenerative diseases are caused by mutations in the mtDNA as well as in 
the nuclear genome and have been linked to defects in mitochondrial respiratory function (Lin 
and Beal, 2006). To investigate the involvement of a mitochondrial respiration defect in the 
pathogenesis of HSP, the respiration rate in isolated brain and spinal cord mitochondria 
lacking paraplegin was assessed. However, we failed to detect any statistically significant 
impairment in mitochondrial oxygen consumption in brain and spinal cord. Since axonal 
degeneration accompanied by mitochondrial abnormalities starts at the synaptic terminals and 
distal regions of affected axons, mitochondrial dysfunction might be confined to this subset of 
mitochondria (Ferreirinha et al., 2004). Nevertheless, analysis of oxygen consumption and 
respiratory chain activities of brain synaptosomes revealed no defect in mitochondrial 
respiratory function (E. Rugarli and A. Bernacchia, personal communication). These 
observations suggest that neurodegeneration due to a lack of paraplegin is not caused by a 
general respiratory dysfunction. However, it cannot be excluded that a suboptimal purification 
of brain synaptosomes might mask a mitochondrial dysfunction. It should be noted that our 
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results contradict observations in fibroblast derived from human HSP patients in which a 
decreased complex I activity was measured (Atorino et al., 2003). But given the tissue-
specific phenotype of HSP, these cells might not be representative models for the affected 
tissues in this disease. Anyhow, a functional mitochondrial respiration does not necessarily 
exclude a defect in mitochondrial respiratory chain activity. The activity of individual 
respiratory complexes can be inhibited up to a tissue-dependent critical value without any 
effect on the rate of mitochondrial respiration or ATP synthesis under normal conditions 
(Rossignol et al., 2000; Rossignol et al., 2003). However, changes in the metabolic state of a 
certain tissues, e.g. energy demands or aging, might lower the threshold to tolerate a 
respiratory chain defect and consequently result in a decrease of respiratory rate (Ventura 
et al., 2002). In fact, paraplegin-deficient mice show only at very old age a defect in ATP-
synthesis in spinal cord mitochondria which further underlines that respiratory defects are not 
the primary molecular cause for the axonal degeneration (Ferreirinha et al., 2004)  
How can the neuron-specific phenotype of HSP be explained despite the ubiquitous 
expression of paraplegin? In most tissues, the presence of m-AAA protease complexes 
composed of only Afg3l1 and Afg3l2 seems to be sufficient to maintain housekeeping 
functions. Thus, neurons might be more susceptible to a reduced number of m-AAA protease 
complexes due to a lack of paraplegin than other tissues. In this respect, substrates of m-AAA 
proteases might be expressed in a tissue-specific manner or their proteolysis might be of 
special importance in specific cells such as neurons. Mice lacking functional Afg3l2 also 
exhibit a neuron-specific phenotype, however much more severe (Maltecca et al., 2008). 
Afg3l2 mutant mice display a strong impairment in axonal development and finally die 
postnatally at day 16 (Maltecca et al., 2008). Furthermore, swollen and giant mitochondria are 
observed primarily in neuronal cell bodies. The stronger phenotype of Afg3l2 mutant mice 
compared to paraplegin-deficient mice can be explained by the higher neuronal abundance of 
Afg3l2 (Koppen et al., 2007). In addition, the inability of paraplegin to homo-oligomerize 
might further lower the presence of functional m-AAA protease complexes (Koppen et al., 
2007). Interestingly, a similar hypothesis was postulated for the neuron-specific phenotype of 
CMT2A caused by mutations in Mfn2 (Detmer and Chan, 2007). Mfn 2 and Mfn 1 are 
supposed to tether opposing mitochondria by forming homo- and hetero-oligomeric 
complexes (Chen et al., 2003; Eura et al., 2003; Koshiba et al., 2004). Therefore, neuron-
specific mitochondrial fusion defects in CMT2A were suggested to arise from low Mfn1 
expression levels in peripheral nerves which results in a reduced number of functional 
mitofusin complexes (Detmer and Chan, 2007). Notably, the phenotypic differences of 
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paraplegin- and Afg3l2-deficient mice cannot only be explained by differences in their 
neuronal abundance but additionally might suggest the existence of specific substrates for 
m-AAA protease isoenzymes differing in their subunit composition, e.g paraplegin-containing 
complexes.  
The putative absence of a detectable respiratory defect in HSP is reminiscent of the 
neurodegenerative disease CMT2A which is characterized by an axonal degeneration mainly 
affecting the longest axons of peripheral neurons (Züchner et al., 2004). The transport of 
mitochondria in axons was significantly impaired in neurons expressing disease-mutated 
forms of Mfn2 due to an abnormal clustering of fragmented mitochondria (Baloh et al., 2007). 
It is conceivable that long axons are preferentially dependent on the trafficking of organelles 
and proteins. Similar to CMT2A, long motor and sensory neurons in the spinal cord are 
mainly affected by a progressive and retrograde degeneration in HSP. The identification of 
HSP causing mutations in proteins implicated in intracellular trafficking indicates that deficits 
in the axonal transport of molecules and organelles play a role for the pathogenesis of HSP 
(Soderblom and Blackstone, 2006). In line with this, old paraplegin-deficient mice exhibit a 
delay in the retrograde axonal transport (Ferreirinha et al., 2004; Rugarli and Langer, 2006). 
This might be caused by an accumulation of morphologically altered and giant mitochondria 
which can be observed already at early stages at synaptic terminals of motor axons in 
paraplegin-deficient mice (Ferreirinha et al., 2004). Thus, an altered mitochondrial 
morphology in the absence of paraplegin might play a role in the pathogenesis of HSP. In this 
respect, it cannot be neglected that paraplegin has been linked to the proteolytic regulation of 
the mitochondrial fusion component OPA1, although the processing of OPA1 is not 
significantly affected in paraplegin-deficient MEFs (Ishihara et al., 2006; Duvezin-Caubet 
et al., 2007). However, it might be envisioned that a certain amount of m-AAA proteases 
complexes or the presence of paraplegin is crucial for OPA1 processing in special cell types 
and/or under certain physiological conditions. 
In summary, an impaired mitochondrial respiration was not observed in brain and 
spinal cord mitochondria of paraplegin-deficient mice. Conclusively, axonal degeneration in 
HSP due to a loss of paraplegin might not arise from a general impairment in mitochondrial 
energy production. To unravel the neuron-specific molecular defects caused by a lack of 
paraplegin, it will be crucial to identify tissue-specific substrates of m-AAA protease 
isoenzymes. Moreover, it remains to be elucidated if paraplegin has special functions within 
m-AAA protease complexes.  
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4.3 Overlapping substrate specificities of Afg3l1 and Afg3l2 in 
 mice and their role in the maturation of paraplegin 
 
In addition to paraplegin, the m-AAA protease subunits Afg3l1 and Afg3l2 are present in 
mice. They both have the ability to form proteolytically active homo-oligomeric m-AAA 
protease complexes which can substitute for paraplegin-containing m-AAA protease 
complexes (Duvezin-Caubet et al., 2007; Koppen et al., 2007). To identify new substrates and 
functions of mammalian m-AAA proteases on a cellular level, single subunits or combinations 
were transiently downregulated in MEFs using RNA interference.  
Mrpl32 is one of the few putative substrates known for mammalian m-AAA proteases. 
Indeed, the precursor of Mrpl32 accumulated upon simultaneous downregulation of Afg3l1 
and Afg3l2 in MEFs pointing to an impaired proteolytic maturation. Nevertheless, processing 
of Mrpl32 still occurs which might be due to cleavage either by residual amounts of Afg3l1 
and Afg3l2 or by another protease with redundant function. Remarkably, as long as either 
Afg3l1 or Afg3l2 are present, processing of Mrpl32 proceeds normally. Thus, homo-
oligomeric complexes composed of Afg3l1 or Afg3l2 are both involved in the maturation of 
Mrpl32. This is substantiated by the ability of these homo-oligomeric m-AAA protease 
isoenzymes to mediate the proteolytic processing of yeast MrpL32 (Koppen et al., 2007). 
Concomitant depletion of Afg3l1 and Afg3l2 also results in an impaired maturation of their 
assembly partner paraplegin. Conclusively, Afg3l1 and Afg3l2 might have at least partially 
overlapping substrate specificities which is underlined by their high sequence identity and the 
lack of AFG3L1 expression in humans (Kremmidiotis et al., 2001). 
The identification of paraplegin as a new substrate for Afg3l1 and Afg3l2 raises the 
questions if cleavage occurs before or after assembly into m-AAA protease complexes. It 
might be well envisioned that m-AAA proteases composed of Afg3l1 and Afg3l2 process 
paraplegin during import and prior to its assembly into hetero-oligomeric complexes. 
Alternatively, the presequence of paraplegin might be removed during or after assembly into 
hetero-oligomeric m-AAA protease complexes through either intra- or intermolecular 
cleavage. This is reminiscent of the assembly-dependent autocatalytic cleavage of preproteins 
of the mitochondrial protease PIM1 in yeast as well as the proteasome (Chen and 
Hochstrasser, 1996; Wagner et al., 1997). PIM1 is processed in two successive steps. First, 
the matrix targeting signal is removed by the mitochondrial processing peptidase and second, 
a pro-region is cleaved off in an autocatalytic reaction (Wagner et al., 1997). The pro-region 
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of PIM1 subunits was shown to be required for efficient sorting to mitochondria which might 
be envisioned for paraplegin as well (Wagner et al., 1997). Alternatively, the presequence 
might inhibit the proteolytic activity of paraplegin-containing m-AAA protease complexes 
and thereby prevent premature proteolytic activity. The activation of proteolytic sites via 
autocatalytic cleavage is exemplified by cleavage of preproteins during proteasome assembly 
(Chen and Hochstrasser, 1996; Baumeister et al., 1998). Furthermore, it is also conceivable 
that the presequence of paraplegin might play a role in the assembly of m-AAA proteases 
which could provide an explanation for the proposed inability of paraplegin to homo-
oligomerize (Koppen et al., 2007). 
 In conclusion, we provide evidence for overlapping substrate specificities of Afg3l1 
and Afg3l2. The efficient processing of Mrpl32 and paraplegin is dependent on the presence 
of Afg3l1 or Afg3l2. Thus, Mrpl32 and paraplegin are identified as new substrates of the 
mammalian m-AAA protease in vivo.  
 
 
 
4.4 The m-AAA protease is involved in the regulation of 
 mitochondrial morphology  
 
 Processing of the mitochondrial fusion protein OPA1 is crucial for the regulation of 
mitochondrial morphology (Duvezin-Caubet et al., 2006; Ishihara et al., 2006). The presence 
of both, long and short OPA1 isoforms is required for mitochondrial fusion (Song et al., 
2007). Several lines of evidence indicate that the mammalian m-AAA protease is involved in 
the processing of OPA1. First, in the presence of a metalloprotease inhibitor, accelerated 
cleavage of long OPA1 isoforms in isolated mitochondria is inhibited pointing to processing 
by a mitochondrial metalloprotease (Ishihara et al., 2006; Guillery et al., 2008). Second, 
reconstitution experiments in yeast revealed that various mammalian m-AAA protease 
isoenzymes are able to cleave OPA1 (Duvezin-Caubet et al., 2007).  
 Indeed, depletion of the murine m-AAA subunits Afg3l1 and Afg3l2 in MEFs led to 
an impaired processing of OPA1. Surprisingly, long OPA1 isoforms were not stabilized but 
drastically reduced accompanied by an accumulation of short OPA1 isoforms. 
Downregulation of human AFG3L2 affects the pattern of OPA1 isoforms in a similar manner. 
The conversion of long into short OPA1 isoforms is also induced upon dissipation of the 
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membrane potential which leads to reduced mitochondrial ATP levels (Duvezin-Caubet et al., 
2006; Baricault et al., 2007; Song et al., 2007; Guillery et al., 2008). MEFs depleted of 
Afg3l1 and Afg3l2 show a partial uncoupling of oxidative phosphorylation. However, his 
partial uncoupling did affect neither mitochondrial membrane potential nor mitochondrial 
respiration which points to a direct function of the mammalian m-AAA protease in the 
biogenesis of OPA1 isoforms.  
Mitochondrial fragmentation observed upon downregulation of Afg3l1 and Afg3l2 could 
be directly ascribed to impaired OPA1 functions since expression of a long OPA1 isoform 
rescues this phenotype at least partially. The requirement of long and short OPA isoforms for 
mitochondrial fusion is consistent with recent findings and implicates that mitochondrial 
fragmentation in Afg3l1/Afg3l2-depleted cells results from the inhibition of fusion rather than 
accelerated fragmentation (Song et al., 2007).  
The phenotypes of cells depleted of the m-AAA-protease subunits Afg3l1 and Afg3l2 are 
highly reminiscent of prohibitin-deficient cells (Merkwirth et al., 2008). Deletion of 
prohibitins in MEFs induces the conversion of long into short OPA1 accompanied by 
mitochondrial fragmentation without any defects in respiratory chain activites (Merkwirth 
et al., 2008). Interestingly, m-AAA proteases and prohibitins physically interact and assemble 
into large supercomplexes in the inner mitochondrial membrane (Steglich et al., 1999; 
Metodiev, 2005). Because deletion of prohibitins in yeast results in accelerated proteolysis of 
m-AAA protease substrates, they are proposed to directly regulate the activity of the m-AAA 
protease or to modulate the accessibility of substrates to the m-AAA protease. A similar 
mechanism was proposed for the E. coli homologues of prohibitins, HflK and HflC, which are 
associated with and negatively modulate the AAA protease FtsH in the bacterial plasma 
membrane (Kihara et al., 1996; Saikawa et al., 2004). If m-AAA proteases are directly 
involved in OPA1 biogenesis, the negative regulation by prohibitins might explain the similar 
consequences on OPA1 isoform pattern upon depletion of these two proteins. Notably, 
concomitant downregulation of m-AAA proteases and prohibitins in MEFs also results in the 
loss of long OPA1 isoforms. Further experiments are needed to clarify the putative regulation 
of m-AAA protease activity by prohibitins in mammals. Since the supercomplex formed by 
m-AAA proteases and prohibitins is disrupted by the depletion of either prohibitins or m-AAA 
proteases, it might also be conceivable that this supercomplex mediates the regulation of 
OPA1 processing. In addition to mitochondrial fragmentation, cristae morphogenesis is highly 
disturbed in prohibitin-deficient cells caused by the selective loss of long OPA1 isoforms 
(Merkwirth et al., 2008). The dependency of cristae morphogenesis on the presence of short 
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and long OPA1 isoforms suggests that cristae morphology is also altered in m-AAA protease-
depleted cells. Likewise, depletion of OPA1 leads to a drastic disorganization of cristae 
membranes in fragmented mitochondria (Olichon et al., 2003; Griparic et al., 2004).  
In conclusion, this study indicates an essential function of m-AAA proteases for 
mitochondrial morphology by regulating the processing of OPA1. Future experiments are 
needed to substantiate the direct link of OPA1 to the m-AAA protease in mammals. So far, 
the possibility that yet unknown functions of the mammalian m-AAA protease affect the 
OPA1 isoform pattern cannnot be excluded. 
 
 
 
4.5 The m-AAA protease is essential for stress-induced 
 mitochondrial hyperfusion 
 
Mitochondria are highly dynamic organelles and they constantly adapt their morphology 
to varying physiological conditions by fusion and fission (Okamoto and Shaw, 2005). Upon 
exposure of cells to stress stimuli such as actinomycin D, UV irridation and cycloheximide, 
mitochondria were observed to hyperfuse and form a highly interconnected network 
(D. Tondera and J.-C. Martinou, personal communication). This stress-induced mitochondrial 
hyperfusion was shown to result mainly from increased fusion activity. However, the 
physiological function is not clear yet, although it might be envisioned that increased 
mitochondrial elongation serves as a stress response to protect cells from mitochondrial 
dysfunction.  
The presence of short and long OPA1 isoforms as well as Mfn1, but not Mfn2, was 
shown to be required for mitochondrial hyperfusion activity (D. Tondera and J.-C. Martinou, 
personal communication). Like OPA1 and Mfn1, the m-AAA protease is essential for the 
maintenance of a tubular mitochondrial network. During stress conditions, also mitochondria 
in Afg3l1/Afg3l2-depleted cells do not form a highly interconnected network but remain 
fragmented. This indicates that m-AAA proteases are essential for fusion events under varying 
physiological conditions. Whether the inability to hyperfuse in Afg3l1/Afg3l2-depleted cells 
is linked to the loss of long OPA1 forms, like it has been shown for steady state fusion events, 
has to be further analyzed.  
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Depletion of prohibitins in MEFs results in mitochondrial fragmentation caused by the 
loss of long OPA1 isoforms (Merkwirth et al., 2008). Remarkably, prohibitin-depleted cells 
which are exposed to stress stimuli contain a highly interconnected mitochondrial network 
pointing to the ability of fragmented mitochondria to hyperfuse in the absence of prohibitins. 
These findings indicate that the prohibitin-mediated control of OPA1 processing is 
dispensable for stress-induced mitochondrial hyperfusion. Conclusively, the supercomplex 
composed of prohibitins and m-AAA proteases controls mitochondrial morphology via OPA1 
in non-stressed cells. However, it does not seem to be involved in the control of mitochondrial 
hyperfusion events pointing to crucial functions of m-AAA proteases in mitochondrial 
morphology independent of prohibitins. 
Since long and short OPA1 isoforms are required for mitochondrial hyperfusion, it is 
quite remarkable that prohibitin-depleted mitochondria, despite the loss of long OPA1 
isoforms, are able to hyperfuse (D. Tondera and J.-C. Martinou, personal communication). It 
might be envisioned that in the absence of prohibitins inner membrane fusion is inhibited via 
OPA1 whereas outer membrane fusion can be activated during mitochondrial hyperfusion. 
Although inner and outer membrane fusion events are coupled in vivo, they have different 
requirements and can proceed separately (Malka et al., 2005). Therefore, a loss of long OPA1 
isoforms most likely affects only inner membrane fusion in spite of an overall mitochondrial 
fragmentation which implies that inner and outer membrane fusion events can negatively 
regulate each other (Meeusen et al., 2006). This raises the question if the loss of prohibitins 
might uncouple inner and outer membrane fusion events after stress treatment, thereby 
allowing outer membranes to fuse. Thus, additional loss of prohibitins in in m-AAA protease- 
and OPA1-depleted mitochondria would rescue the defect in mitochondrial hyperfusion. 
However, downregulation of prohibitins did not suppress the requirement of the m-AAA 
protease or OPA1 for mitochondrial hyperfusion. Conclusively, prohibitins are most likely not 
involved in the regulation of outer and inner membrane fusion. It remains unclear, how the 
distinct outer and inner membrane fusion machineries are linked to each other. In 
S. cerevisiae, the outer membrane protein Ugo1 physically interacts with the mitofusin 
homologue Fzo1 and the OPA1 homologue Mgm1 providing a link that might coordinate 
outer and inner membrane fusion (Wong et al., 2003; Sesaki and Jensen, 2004). However, a 
mammalian homologue of Ugo1 has not been identified. Recently, OPA1 has been 
demonstrated to interact with both mitofusins by crosslinking experiments which points to 
transient interactions (Guillery et al., 2008). Therefore, it is tempting to speculate that OPA1 
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isoforms do not only mediate inner membrane fusion but also regulate the coordination with 
the outer membrane fusion machinery by direct interactions.  
The requirement of prohibitins for mitochondrial dynamics during steady state but not 
during stress conditions might also indicate that a protein homologous to prohibitins exists 
which acts in mitochondrial hyperfusion. The stomatin-like 2 protein (SLP-2), sharing the 
highly conserved SPFH-domain with prohibitins, was shown to be required for mitochondria 
to hyperfuse (Tavernarakis et al., 1999; Browman et al., 2007) (D. Tondera and J.-C. 
Martinou, personal communication). In contrast to prohibitins, depletion of SLP-2 has no 
effect on mitochondrial morphology in non-stressed cells (Hajek et al., 2007). These findings 
indicate that different proteins and mechanisms for the regulation of mitochondrial fusion 
events exist. The fusion machinery which is needed for maintenance of a tubular 
mitochondrial network requires prohibitins, whereas for stress-induced mitochondrial 
hyperfusion SLP-2 might be essential. The homology of prohibitins and SLP-2 points to 
similar functions in these distinct fusion events. Indeed, reminiscent of the function of  
prohibitins in non-stressed cells, SLP-2 was proposed to regulate mitochondrial 
morphogenesis during stress by controlling the processing of OPA1 (D. Tondera and J.-C. 
Martinou, personal communication) (Merkwirth et al., 2008). Thus, the different requirments 
of prohibitins and SLP-2 in the mitochondrial fusion events might point to the existence of a 
specific protein machinery executing stress-induced mitochondrial hyperfusion 
In conclusion, crucial functions of the m-AAA protease in the regulation of 
mitochondrial morphology independent of prohibitins have been identified. Whether the 
m-AAA protease directly regulates mitochondrial hyperfusion via OPA1 remains to be 
established.  
 
 
4.6 The m-AAA protease controls the processing of OPA1 
 
So far, several mitochondrial proteases have been implicated in the proteolysis of OPA1. 
In addition to the m-AAA protease, the rhomboid protease PARL and the i-AAA protease 
were proposed to process long OPA1 isoforms. PARL was suggested to be responsible for the 
generation of a small amount of short OPA1 isoforms (Cipolat et al., 2006). Nevertheless, the 
OPA1 isoform pattern is not drastically affected in PARL-deficient cells indicating that the 
majority of OPA1 isoforms can be generated in the absence of PARL (Duvezin-Caubet et al., 
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2007; Griparic et al., 2007). Downregulation of the i-AAA protease Yme1l1 clearly impairs 
the constitutive cleavage of long OPA1 isoforms at cleavage site S2, ALthough it remains to 
be demonstrated whether Yme1l1 directly cleaves OPA1 or affects another protease (Griparic 
et al., 2007; Song et al., 2007).  
In this study, transfection of cells with different OPA1 isoforms revealed an increased 
cleavage of long OPA1 isoforms at cleavage site S1, but not S2, in the absence of the m-AAA 
protease subunits Afg3l1 and Afg3l2. Furthermore, long OPA1 isoforms were degraded in an 
accelerated manner which might indicate that these membrane-anchored OPA1 isoforms are 
stabilized by the m-AAA protease. In contrast, short OPA1 isoforms which are only 
peripherally attached to the membrane are not destabilized upon depletion of the m-AAA 
protease. Interestingly, dissipation of the mitochondrial membrane potential affects OPA1 
processing in a similar manner and resulted in an accelerated cleavage at processing site S1 
(Song et al., 2007). It is tempting to speculate that reduced ATP synthesis upon the loss of 
membrane potential might compromise the function of the ATP-dependent m-AAA protease 
and induces cleavage by an ATP-independent protease. 
Which mitochondrial protease(s) cleave(s) OPA1 at processing site S1? Constitutive and 
inducible OPA1 processing in cells devoid of the mitochondrial proteases PARL, HtrA2 or 
the murine m-AAA protease subunit paraplegin proceeds comparably to control cells. Also, 
downregulation of the mitochondrial matrix protease Lon or the i-AAA protease Yme1l1 did 
not strikingly affect cleavage at processing site S1 independent of Afg3l1 and Afg3l2. 
Therefore, all tested mitochondrial proteases are dispensable for processing at site S1. This 
might either reflect the presence of various proteases with redundant functions or the 
existence of a yet unidentified protease. Protease inhibitor studies in cells depleted of Afg3l1 
and Afg3l2 revealed the stabilization of newly synthesized long OPA1 and its precursor in the 
presence of an inhibitor for metalloproteases as well as for the proteasome, which was 
recently implicated in the cytosolic degradation of mitochondrial precursor proteins 
(Margineantu et al., 2007; Radke et al., 2008). The accumulation of newly synthesized OPA1 
and its precursor through inhibition of metalloproteases is most likely caused by blocking the 
Zn2+-dependent mitochondrial processing peptidase MPP in the matrix (Luciano et al., 1998). 
Therefore, no clear conclusion can be drawn about metal-dependent processing events 
affecting OPA1 downstream of MPP cleavage.  
How does the m-AAA protease affect the biogenesis of OPA1? On the one hand, yeast 
reconstitution experiments provided direct evidence for the ability of mammalian m-AAA 
protease complexes to cleave OPA1 (Duvezin-Caubet et al., 2007). On the other hand, in the 
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absence of the m-AAA protease in mammalian cells OPA1 processing not only occurs but is 
accelerated and accompanied by the destabilisation of long OPA1 isoforms. Combining these 
two observations in a model would first imply that the constitutive and the induced cleavage 
of long OPA1 isoforms are performed by different proteases. Whereas the protease(s) for the 
induced processing at site S1 remain(s) to be identified, the m-AAA protease might process 
OPA1 constitutively at cleavage site S1. In addition, it could be envisioned that the m-AAA 
protease has a non-proteolytic function in the biogenesis of long OPA1 isoforms which is 
needed for the subsequent m-AAA protease-dependent OPA1 processing. Since the putative 
cleavage product of Yme1l1, the OPA1 isoform S4, is also reduced in Afg3l1/Afg3l2-
depleted cells, the non-proteolytic function of the m-AAA protease might also regulate OPA1 
cleavage by the i-AAA protease (Griparic et al., 2007; Song et al., 2007). This hypothesis is 
supported by the identification of a non-proteolytic function of the m-AAA protease in yeast. 
The bipartite presequence of Ccp1 is removed by the consecutive actions of the m-AAA 
protease and the rhomboid protease Pcp1 (Esser et al., 2002). Strikingly, the final cleavage of 
Ccp1 by the rhomboid protease depends only on the ATP-dependent membrane translocation 
of Ccp1 which is mediated by the m-AAA protease (Tatsuta et al., 2007). Ccp1 processing in 
m-AAA protease-deficient yeast cells is restored upon expression of proteolytically active and 
inactive human AFG3L2 complexes, which strongly suggests that the ability for membrane 
dislocation is conserved in mammalian m-AAA proteases (Koppen, 2007). Interestingly, the i-
AAA protease was also found to be required for the import of mammalian PNPase into the 
intermembrane space of yeast mitochondria consistent with a function for membrane 
translocation (Rainey et al., 2006). Therefore, it might be conceivable that the m-AAA 
protease mediates the vectorial membrane translocation of OPA1 after MPP cleavage to allow 
subsequent processing by the m-AAA protease on the matrix side. In this context, m-AAA 
protease-dependent lateral sorting of long OPA1 isoforms and their stable integration into the 
inner membrane might be envisioned as well. Notably, cleavage of the OPA1 homologue 
Mgm1 in yeast depends also on ATP-dependent vectorial membrane translocation though 
exerted directly by the mitochondrial import motor Hsp70 (Herlan et al., 2004).  
 In summary, these findings reveal that the m-AAA protease is involved in the regulation 
of OPA1 cleavage at processing S1 and is required for the stabilisation of long OPA1 
isoforms. Further studies are clearly needed to substantiate the hypothesis that membrane 
translocation of OPA1 is mediated by the m-AAA protease and is required for constitutive 
processing of OPA1.  
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5 Zusammenfassung 
Die m-AAA Protease, ein ATP-abhängiger proteolytischer Komplex in der inneren 
mitochondrialen Membran, kontrolliert in Hefe die mitochondriale Proteinqualität und 
reguliert durch ihre Funktion als Prozessierungsenzym die mitochondriale Proteinsynthese. 
Die m-AAA Proteasen in Säugern assemblieren in verschiedene Isoenzyme, die aus 
unterschiedlichen Untereinheiten bestehen. In der Maus werden die drei Untereinheiten 
Afg3l1, Afg3l2 und Paraplegin gewebespezifisch exprimiert. Mutationen in der m-AAA 
Proteaseuntereinheit Paraplegin führen zu hereditärer spastischer Paraplegie (HSP), einer 
neurodegenerativen Krankheit, die durch eine zellspezifische axonale Degeneration 
gekennzeichnet ist. Mäuse, die Mutationen in der Untereinheit Afg3l2 tragen, weisen 
ebenfalls neuropathologische Symptome auf und haben einen starken Defekt in der axonalen 
Entwicklung. Die molekulare Grundlage dieser neuronen-spezifischen Phänotypen sowie die 
Funktionen der m-AAA Proteasen in Säugern im Allgemeinen sind unklar und wurden in 
dieser Arbeit untersucht. 
Die Analyse eines Mausmodels für HSP enthüllte einen leberspezifischen Defekt der 
mitochondrialen Proteinsynthese, der auf eine Konservierung der m-AAA Protease-
vermittelten Kontrolle der mitochondrial Proteinsynthese in Säugern hindeutet. Eine 
signifikanter Beeinträchtigung der mitochondrialen Proteinsynthese wie auch der 
mitochondrialen Atmung konnte in Gehirn und Rückenmark jedoch nicht beobachtet werden. 
Dies lässt vermuten, dass die axonale Degeneration in HSP nicht durch einen generellen 
mitochondrialen Atmungsdefekt verursacht wird. 
Die Analyse der m-AAA Isoenzyme auf zellulärer Ebene durch RNA Interferenz ergab 
redundante Funktionen der Untereinheiten Afg3l1 und Afg3l2 und identifizierte Paraplegin 
als ein neues Substrat, welches von Afg3l1 und Afg3l2 prozessiert wird. Der Verlust der 
m-AAA Protease in MEFs führte zu einer Fragmentierung der Mitochondrien, begleitet von 
einer gestörten Biogenese von Isoformen der mitochondrialen Fusionskomponente OPA1. 
Lange OPA1 Isoformen wurden destabilisiert und in einer beschleunigten Weise prozessiert. 
Die Überexpression einer langen OPA1 Isoform in Zellen, in denen die m-AAA Protease 
depletiert wurde, führte zu einer Wiederherstellung des tubulären mitochondrial Netzwerkes. 
Dies identifizierte die beeinträchtigte OPA1 Prozessierung als Hauptgrund für den Defekt der 
mitochondrialen Morphologie. Zudem konnte gezeigt werden, dass die m-AAA Protease 
essentiell für die Induzierung der mitochondrialen Hyperfusion ist, einer zellulären 
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Stressantwort, welche zu einem stark zusammenhängenden mitochondrialen Netzwerk in der 
Zelle führt. 
Die Befunde dieser Arbeit lassen auf eine entscheidende Funktion der m-AAA Protease 
in der Regulation der mitochondrialen Morphologie schliessen, möglicherweise durch die 
Kontrolle der Biogenese von OPA1. Dies könnte dazu beitragen, neue Einsichten in die 
molekularen Mechanismen der Axonopathien zu erhalten, welche durch den Verlust von 
m-AAA Proteaseuntereinheiten in Säugern entstehen.  
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7 List of Abbreviations 
AAA   ATPases associated with a variety of cellular activities 
Aβ   amyloid β−peptide 
ADOA  autosomal domaint optic atrophy 
ADP   adenosine diphosphate 
APP   amyloid precursor protein 
APS   ammoniumperoxo disulfate 
ATP   adenosine triphosphate 
bp   base pairs 
CCCP   carbonyl cyanide m-chlorophenylhydrazone 
cDNA   complementary DNA 
CMT2A  Charcot-Marie-Tooth type 2A 
C-terminal  carboxyterminal 
C-terminus  carboxy terminus 
DMSO  dimethyl sulfoxide 
DNA   deoxyribonucleic acid 
EDTA   ethylene diamine tetraacetic acid 
Fig.   Figure 
g   standard gravity 
GTP   guanosine triphosphate 
h   hour(s) 
HCl   hydrochloric acid 
HEPES  N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic-acid 
HSP   hereditary spastic paraplegia 
K   potassium 
kb   kilobase pairs 
KCl   potassium chloride 
kDa   kilodalton 
KOH   potassium hydroxide 
m   meter 
M   molar (mole per liter) 
MDa   megadalton 
MEF   mouse embryonic fibroblast 
µg   microgram 
µl   microliter 
mg   milligram 
ml   milliliter 
Mg   magnesium 
min   minute(s) 
MIP   mitochondrial intermediate peptidase 
mM   millimolar 
mRNA  messenger RNA 
Mg   magnesium  
MPP   mitochondrial processing peptidase 
mRNA  messenger RNA 
mt   mitochondrial 
mtDNA  mitochondrial DNA 
MTS   mitochondrial targeting sequence 
NaCl   sodium chloride 
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NADH  nicotinamide adenine dinucleotide (reduced form) 
NaOH   sodium hydroxide 
NP-40   Nonidet P-40 
N-terminal  aminoterminal 
N-terminus  amino terminus 
OXPHOS  oxidative phosphorylation 
PAGE   polyacrylamide gel electrophoresis 
PBS   phosphate buffered saline 
PCR   polymerase chain reaction 
PMSF   phenylmethylsulphonyl fluoride 
RNA   ribonucleic acid 
RNAi   RNA interference 
ROS   reactive oxygen species 
rpm   rounds per minute 
RT   room temperature 
s   second(s) 
SDS   sodium dodecyl sulfate 
SPG   spastic paraplegia gene 
SRH   second region of homology 
Tab.   Table 
TBS   Tris buffered saline 
TCA   trichloracetic acid 
TEMED  N,N,N',N'-Tetramethylethylenediamine 
TIM   translocase of the inner membrane 
TM   transmembrane domain 
TOM   translocase of the outer membrane 
Tris   2-amino-2-(hydroxymethyl)-1,3-propandiole 
U   unit(s) 
UPS   ubiquitin-proteasome system 
v/v   volume per volume 
V   volt 
wt   wild-type 
w/v   weight per volume 
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Teilpublikationen im Rahmen dieser Arbeit: 
 
Nolden, M., Ehses, S., Koppen, M., Bernacchia, A., Rugarli, E. I., and Langer, T. (2005) 
 
“The m-AAA Protease Defective in Hereditary Spastic Paraplegia Controls Ribosome 
Assembly in Mitochondria.” 
 
Cell 123, 277-289 
 
Abstract: 
 
AAA proteases comprise a conserved family of membrane bound ATP-dependent proteases 
that ensures the quality control of mitochondrial inner-membrane proteins. Inactivation of 
AAA proteases causes pleiotropic phenotypes in various organisms, including respiratory 
deficiencies, mitochondrial morphology defects, and axonal degeneration in hereditary spastic 
paraplegia (HSP). The molecular basis of these defects, however, remained unclear. Here, we 
describe a regulatory role of an AAA protease for mitochondrial protein synthesis in yeast. 
The mitochondrial ribosomal protein MrpL32 is processed by the m-AAA protease, allowing 
its association with preassembled ribosomal particles and completion of ribosome assembly in 
close proximity to the inner membrane. Maturation of MrpL32 and mitochondrial protein 
synthesis are also impaired in a HSP mouse model lacking the m-AAA protease subunit 
paraplegin, demonstrating functional conservation. Our findings therefore rationalize 
mitochondrial defects associated with m-AAA protease mutants in yeast and shed new light 
on the mechanism of axonal degeneration in HSP. 
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